1
|
Pan X, Xu C, Cheng G, Chen Z, Liu M, Mei Y. Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote mitoxantrone resistance in stomach adenocarcinoma. Mol Biol Rep 2024; 51:90. [PMID: 38194158 DOI: 10.1007/s11033-023-08933-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Accepted: 10/10/2023] [Indexed: 01/10/2024]
Abstract
BACKGROUND CDC25B, as a member of the cell cycle regulating protein family, is located in the cytoplasm and is involved in the transition of the cell cycle and mitosis. CDC25B is highly expressed in various tumors and is a newly discovered oncogene. This study aimed to investigate the impact of CDC25B on mitoxantrone resistance in stomach adenocarcinoma (STAD) and its possible mechanisms. METHODS This study analyzed the expression of CDC25B and its potential transcription factor E2F3 in STAD, as well as the IC50 values of tumor tissues by bioinformatics analysis. Expression levels of CDC25B and E2F3 in STAD cells were measured by qRT-PCR. MTT was utilized to evaluate cell viability and IC50 values of STAD cells, and comet assay was utilized to analyze the level of DNA damage in STAD cells. Western blot was used to analyze the expression of DNA damage-related proteins. The targeting relationship between E2F3 and CDC25B was validated by dual-luciferase and ChIP assays. RESULTS Bioinformatics analysis and molecular experiments showed that CDC25B and E2F3 were highly expressed in STAD, and CDC25B was enriched in the mismatch repair and nucleotide excision repair pathways. The IC50 values of tumor tissues with high expression of CDC25B were relatively high. Dual-luciferase and ChIP assays confirmed that CDC25B could be transcriptionally activated by E2F3. Cell experiments revealed that CDC25B promoted mitoxantrone resistance in STAD cells by regulating DNA damage. Further research found that low expression of E2F3 inhibited mitoxantrone resistance in STAD cells by DNA damage, but overexpression of CDC25B reversed the impact of E2F3 knockdown on mitoxantrone resistance in STAD cells. CONCLUSION This study confirmed a novel mechanism by which E2F3/CDC25B mediated DNA damage to promote mitoxantrone resistance in STAD cells, providing a new therapeutic target for STAD treatment.
Collapse
Affiliation(s)
- Xiaoming Pan
- Department of Gastrointestinal Surgery, Lishui People's Hospital, No.15 Dazhong Street, Liandu District, Lishui, Zhejiang Province, 323000, China
| | - Chaobo Xu
- Department of Gastrointestinal Surgery, Lishui People's Hospital, No.15 Dazhong Street, Liandu District, Lishui, Zhejiang Province, 323000, China
| | - Guoxiong Cheng
- Department of Gastrointestinal Surgery, Lishui People's Hospital, No.15 Dazhong Street, Liandu District, Lishui, Zhejiang Province, 323000, China
| | - Zhengwei Chen
- Department of Gastrointestinal Surgery, Lishui People's Hospital, No.15 Dazhong Street, Liandu District, Lishui, Zhejiang Province, 323000, China
| | - Ming Liu
- Department of Gastrointestinal Surgery, Lishui People's Hospital, No.15 Dazhong Street, Liandu District, Lishui, Zhejiang Province, 323000, China
| | - Yijun Mei
- Department of Gastrointestinal Surgery, Lishui People's Hospital, No.15 Dazhong Street, Liandu District, Lishui, Zhejiang Province, 323000, China.
| |
Collapse
|
2
|
Zang J, Zhang J, Mei Y, Xiong Y, Ci T, Feng N. Immunogenic dead cells engineered by the sequential treatment of ultraviolet irradiation/cryo-shocking for lung-targeting delivery and tumor vaccination. Biomater Sci 2023; 12:164-175. [PMID: 37947455 DOI: 10.1039/d3bm00854a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2023]
Abstract
Chemoimmunotherapy is a promising strategy in tumor treatments. In this study, immunogenic dead cells were engineered by the sequential treatment of live tumor cells with ultraviolet (UV) irradiation and cryo-shocking. The dead cells could serve as a lung-targeting vehicle and tumor vaccine after differential loading of the chemo-drug 10-hydroxycamptothecin (HCPT) and immune adjuvant Quillaja saponin-21 (QS-21) via physical absorption and chemical conjugation, respectively. After intravenous administration, the dead cells could be trapped in pulmonary capillaries and could fast release HCPT to enhance the drug accumulation in local tissues. Further, the immunogenic dead cells elicited antitumor immune responses together with the conjugated adjuvant QS-21 to achieve the elimination and long-term surveillance of tumor cells. In a lung tumor-bearing mice model, this drug-delivery system achieved synergistic antitumor efficacy and prolonged the survival of mice.
Collapse
Affiliation(s)
- Jing Zang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
| | - Jinniu Zhang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
| | - Yijun Mei
- School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu province, 210009, China
| | - Yaoxuan Xiong
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
| | - Tianyuan Ci
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
| | - Nianping Feng
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
| |
Collapse
|
3
|
Adams DQ, Alduino C, Alfonso K, Avignone FT, Azzolini O, Bari G, Bellini F, Benato G, Biassoni M, Branca A, Brofferio C, Bucci C, Camilleri J, Caminata A, Campani A, Canonica L, Cao XG, Capelli S, Cappelli L, Cardani L, Carniti P, Casali N, Chiesa D, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick RJ, D'Addabbo A, Dafinei I, Davis CJ, Dell'Oro S, Di Domizio S, Dompè V, Fang DQ, Fantini G, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fu SH, Fujikawa BK, Giachero A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Han K, Heeger KM, Huang RG, Huang HZ, Johnston J, Keppel G, Kolomensky YG, Ligi C, Ma L, Ma YG, Marini L, Maruyama RH, Mayer D, Mei Y, Moggi N, Morganti S, Napolitano T, Nastasi M, Nikkel J, Nones C, Norman EB, Nucciotti A, Nutini I, O'Donnell T, Ouellet JL, Pagan S, Pagliarone CE, Pagnanini L, Pallavicini M, Pattavina L, Pavan M, Pessina G, Pettinacci V, Pira C, Pirro S, Pozzi S, Previtali E, Puiu A, Rosenfeld C, Rusconi C, Sakai M, Sangiorgio S, Schmidt B, Scielzo ND, Sharma V, Singh V, Sisti M, Speller D, Surukuchi PT, Taffarello L, Terranova F, Tomei C, Vetter KJ, Vignati M, Wagaarachchi SL, Wang BS, Welliver B, Wilson J, Wilson K, Winslow LA, Zimmermann S, Zucchelli S. Erratum: Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE [Phys. Rev. Lett. 126, 171801 (2021)]. Phys Rev Lett 2023; 131:249902. [PMID: 38181163 DOI: 10.1103/physrevlett.131.249902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Indexed: 01/07/2024]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.126.171801.
Collapse
|
4
|
Wang S, Mei Y, Yang ZY, Zhang Q, Li RL, Wang YY, Zhao WH, Xu T. [Comparison of two child growth standards in assessing the nutritional status of children under 6 years of age]. Zhonghua Er Ke Za Zhi 2023; 61:700-707. [PMID: 37528010 DOI: 10.3760/cma.j.cn112140-20230505-00314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 08/03/2023]
Abstract
Objective: To compare the application of China growth standard for children under 7 years of age (China standards) and World Health Organization child growth standards (WHO standards) in evaluating the prevalence of malnutrition in children aged 0-<6 years in China. Methods: The research data came from the national special program for science & technology basic resources investigation of China, named "2019-2021 survey and application of China's nutrition and health system for children aged 0-18 years". Multi-stage stratified random sampling was used to recruit 28 districts (regions) in 14 provinces, autonomous regions or municipalities across the country. Children (n=38 848) were physically measured and questionnaires were conducted in the guardians of the children. The indicators of stunting, underweight, wasting, overweight and obesity were evaluated by China standards and WHO standards respectively. Chi-square test was used to comparing the prevalence of each nutritional status between the two standards, as well as the comparison between the two standards by gender and age. Results: Among the 38 848 children, 19 650 were boys (50.6%) and 19 198 were girls (49.4%), 19 480 urban children (50.1%) and 19 368 rural children (49.9%). The stunting, underweight and wasting cases in the study population were 2 090 children (5.4%), 1 354 children (3.5%) and 1 276 children (3.3%) according to the China standards, and 1 474 children (3.8%), 701 children (1.8%) and 824 children (2.1%) according to the WHO standards, respectively; the above rates according to the China standards were slightly higher than those to the WHO standards (χ2=111.59, 213.14, and 99.99, all P<0.001). The overweight and obesity cases in the study population were 2 186 children (5.6%) and 1 153 children (3.0%) according to the China standards, and 2 210 children (5.7%) and 1 186 children (3.1%) according to the WHO standards, with no statistically significant differences (χ2=0.14 and 0.48, P=0.709 and 0.488, respectively). Compared to the results based on WHO standards, the China standards showed a lower prevalence of overweight and obesity in boys (χ2=14.95 and 5.85, P<0.001 and =0.016, respectively), and higher prevalence of overweight in girls (χ2=12.60, P<0.001); but there was no statistically significant differences in girls' obesity prevalence between the two standards (χ2=2.62, P=0.106). Conclusions: In general, the prevalence of malnutrition among children aged 0-<6 years based on China standards is slightly higher than that on WHO standards. To evaluate the nutritional status of children, it is advisable to select appropriate child growth standards based on work requirements, norms or research objectives.
Collapse
Affiliation(s)
- S Wang
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - Y Mei
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| | - Z Y Yang
- National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Q Zhang
- National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - R L Li
- Department of Children Health and Development, Capital Institute of Pediatrics, Beijing 100020, China
| | - Y Y Wang
- National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - W H Zhao
- National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - T Xu
- National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China
| |
Collapse
|
5
|
Adams DQ, Alduino C, Alfonso K, Avignone FT, Azzolini O, Bari G, Bellini F, Benato G, Beretta M, Biassoni M, Branca A, Brofferio C, Bucci C, Camilleri J, Caminata A, Campani A, Canonica L, Cao XG, Capelli S, Capelli C, Cappelli L, Cardani L, Carniti P, Casali N, Celi E, Chiesa D, Clemenza M, Copello S, Cremonesi O, Creswick RJ, D'Addabbo A, Dafinei I, Del Corso F, Dell'Oro S, Di Domizio S, Di Lorenzo S, Dompè V, Fang DQ, Fantini G, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fu SH, Fujikawa BK, Ghislandi S, Giachero A, Gianvecchio A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Han K, Hansen EV, Heeger KM, Huang RG, Huang HZ, Johnston J, Keppel G, Kolomensky YG, Kowalski R, Liu R, Ma L, Ma YG, Marini L, Maruyama RH, Mayer D, Mei Y, Morganti S, Napolitano T, Nastasi M, Nikkel J, Nones C, Norman EB, Nucciotti A, Nutini I, O'Donnell T, Olmi M, Ouellet JL, Pagan S, Pagliarone CE, Pagnanini L, Pallavicini M, Pattavina L, Pavan M, Pessina G, Pettinacci V, Pira C, Pirro S, Pozzi S, Previtali E, Puiu A, Quitadamo S, Ressa A, Rosenfeld C, Sangiorgio S, Schmidt B, Scielzo ND, Sharma V, Singh V, Sisti M, Speller D, Surukuchi PT, Taffarello L, Terranova F, Tomei C, Vetter KJ, Vignati M, Wagaarachchi SL, Wang BS, Welliver B, Wilson J, Wilson K, Winslow LA, Zimmermann S, Zucchelli S. New Direct Limit on Neutrinoless Double Beta Decay Half-Life of ^{128}Te with CUORE. Phys Rev Lett 2022; 129:222501. [PMID: 36493444 DOI: 10.1103/physrevlett.129.222501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 07/22/2022] [Accepted: 10/03/2022] [Indexed: 06/17/2023]
Abstract
The Cryogenic Underground Observatory for Rare Events (CUORE) at Laboratori Nazionali del Gran Sasso of INFN in Italy is an experiment searching for neutrinoless double beta (0νββ) decay. Its main goal is to investigate this decay in ^{130}Te, but its ton-scale mass and low background make CUORE sensitive to other rare processes as well. In this Letter, we present our first results on the search for 0νββ decay of ^{128}Te, the Te isotope with the second highest natural isotopic abundance. We find no evidence for this decay, and using a Bayesian analysis we set a lower limit on the ^{128}Te 0νββ decay half-life of T_{1/2}>3.6×10^{24} yr (90% CI). This represents the most stringent limit on the half-life of this isotope, improving by over a factor of 30 the previous direct search results, and exceeding those from geochemical experiments for the first time.
Collapse
Affiliation(s)
- D Q Adams
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Alduino
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Alfonso
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - O Azzolini
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - G Bari
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - F Bellini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - G Benato
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Beretta
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Biassoni
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A Branca
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Brofferio
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Bucci
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - J Camilleri
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - A Caminata
- INFN-Sezione di Genova, Genova I-16146, Italy
| | - A Campani
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Canonica
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - X G Cao
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - S Capelli
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Capelli
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cappelli
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - L Cardani
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - P Carniti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - N Casali
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - E Celi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - D Chiesa
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Clemenza
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Copello
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - O Cremonesi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - R J Creswick
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A D'Addabbo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - I Dafinei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - F Del Corso
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - S Dell'Oro
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Di Domizio
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - S Di Lorenzo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - V Dompè
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - D Q Fang
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - G Fantini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - M Faverzani
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Ferri
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - F Ferroni
- INFN-Sezione di Roma, Roma I-00185, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - E Fiorini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M A Franceschi
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - S J Freedman
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S H Fu
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - B K Fujikawa
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Ghislandi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - A Giachero
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Gianvecchio
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Gironi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Giuliani
- Universit Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Gorla
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - C Gotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - T D Gutierrez
- Physics Department, California Polytechnic State University, San Luis Obispo, California 93407, USA
| | - K Han
- INPAC and School of Physics and Astronomy, Shanghai Jiao Tong University; Shanghai Laboratory for Particle Physics and Cosmology, Shanghai 200240, China
| | - E V Hansen
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - K M Heeger
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - R G Huang
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - H Z Huang
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - J Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - G Keppel
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - Yu G Kolomensky
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Kowalski
- Department of Physics and Astronomy, The Johns Hopkins University, 3400 North Charles Street Baltimore, Maryland 21211, USA
| | - R Liu
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - L Ma
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - Y G Ma
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - L Marini
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - R H Maruyama
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - D Mayer
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Y Mei
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Morganti
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - T Napolitano
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - M Nastasi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - J Nikkel
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C Nones
- IRFU, CEA, Universit Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - E B Norman
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - A Nucciotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - I Nutini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - T O'Donnell
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - M Olmi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - J L Ouellet
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Pagan
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C E Pagliarone
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - L Pagnanini
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Pallavicini
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Pattavina
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Pavan
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - G Pessina
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | | | - C Pira
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - S Pirro
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - S Pozzi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Previtali
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Puiu
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - S Quitadamo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - A Ressa
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - C Rosenfeld
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Sangiorgio
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - B Schmidt
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N D Scielzo
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - V Sharma
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - V Singh
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Sisti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - D Speller
- Department of Physics and Astronomy, The Johns Hopkins University, 3400 North Charles Street Baltimore, Maryland 21211, USA
| | - P T Surukuchi
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | | | - F Terranova
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Tomei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - K J Vetter
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Vignati
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S L Wagaarachchi
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B S Wang
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - B Welliver
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - L A Winslow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Zimmermann
- Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Zucchelli
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum-Università di Bologna, Bologna I-40127, Italy
| |
Collapse
|
6
|
Pan X, Xu C, Cheng G, Chen Z, Liu M, Mei Y. High-Performance Circulating Tumor DNA Liquid Biopsy Based on Graphitic Carbon Nitride Nanosheet for Monitoring Gastric Cancer-Related Gene Mutations. J Biomed Nanotechnol 2022. [DOI: 10.1166/jbn.2022.3417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Early diagnosis and timely monitoring of cancer progression are the most effective ways to improve the cure rate of cancer patients. And it is essential to create convenient, sensitive, accurate, as well as noninvasive or minimally invasive tests for better respecting patients’
wishes and optimizing diagnosis. The fluorescent biosensor discovered in our study on the basis of graphitic carbon nitride nanosheet (CNNS) could be used to detect the gastric cancer-associated circulating tumor DNA (ctDNA) in human blood by highly specific binding to fluorescein-labeled
single-stranded DNA detection probes. The ssDNA detection probe was adsorbed on the surface of CNNS through weak Π–Π stacking, thereby obtaining efficient fluorescence quenching. With the presence of the target DNA, the ssDNA probe showed weak affinity for CNNS and restored
fluorescence by base complementary pairing with target ssDNA through strong hydrogen bonds. The results show that the nanometer detection is a convenient, low-cost and high-efficiency technology, which is promising in biological detection and analysis.
Collapse
Affiliation(s)
- Xiaoming Pan
- Department of Gastrointestinal Surgery, Lishui People’s Hospital, Lishui, Zhejiang, 323000, China
| | - Chaobo Xu
- Department of Gastrointestinal Surgery, Lishui People’s Hospital, Lishui, Zhejiang, 323000, China
| | - Guoxiong Cheng
- Department of Gastrointestinal Surgery, Lishui People’s Hospital, Lishui, Zhejiang, 323000, China
| | - Zhengwei Chen
- Department of Gastrointestinal Surgery, Lishui People’s Hospital, Lishui, Zhejiang, 323000, China
| | - Ming Liu
- Department of Gastrointestinal Surgery, Lishui People’s Hospital, Lishui, Zhejiang, 323000, China
| | - Yijun Mei
- Department of Gastrointestinal Surgery, Lishui People’s Hospital, Lishui, Zhejiang, 323000, China
| |
Collapse
|
7
|
Kubota S, Ho J, McDonald A, Tata N, Asaadi J, Guenette R, Battat J, Braga D, Demarteau M, Djurcic Z, Febbraro M, Gramellini E, Kohani S, Mauger C, Mei Y, Newcomer F, Nishimura K, Nygren D, Van Berg R, Varner G, Woodworth K. Enhanced low-energy supernova burst detection in large liquid argon time projection chambers enabled by Q-Pix. Int J Clin Exp Med 2022. [DOI: 10.1103/physrevd.106.032011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
8
|
Xu C, Chen Z, Pan X, Liu M, Cheng G, Li J, Mei Y. Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs. Appl Biochem Biotechnol 2022; 194:6255-6269. [PMID: 35904674 DOI: 10.1007/s12010-022-04098-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/15/2022] [Indexed: 11/29/2022]
Abstract
Progression, prognosis, and therapeutic strategy of stomach adenocarcinoma (STAD) have a close connection with tumor microenvironment (TME). Thus, it is pivotal to delve into the TME and immune-related genes, which may bring possibilities for improving patient's prognosis. TCGA-STAD dataset was analyzed to acquire differentially expressed lncRNAs in tumor samples, which were overlapped with the immune-related lncRNA datasets in the ImmLnc database. Twenty-six lncRNAs related to STAD immunity and patient's prognosis were acquired by univariate Cox analysis. Following lncRNA expression patterns, STAD samples could be classified into two clusters with completely different immune patterns. We performed multivariate Cox regression analysis on lncRNAs to identify 7-feature lncRNAs and constructed a corresponding prognostic model. The model validity was verified by survival analysis and ROC curve in validation and training sets. To explore connection between model and TME and tumor drug resistance, this study analyzed differences in immune cell infiltration between samples from high- and low-risk groups and then revealed immune cells follicular helper with significant differences in tumor tissue infiltration. Analysis of resistance to chemotherapeutic drugs revealed that samples in the high-risk group had resistance to cisplatin, doxorubicin, bleomycin, and gemcitabine. Through univariate and multivariate Cox analyses, we manifested that risk score could be an independent prognostic factor. Combining risk score and clinical factors, a nomogram was constructed to accurately predict patient's prognosis. This model can effectively predict prognosis, TME, and drug resistance of STAD patients, which may provide a reference for tumor development evaluation and precise treatment for clinical STAD.
Collapse
Affiliation(s)
- Chaobo Xu
- Department of Gastrointestinal Surgery, Lishui City People's Hospital, 15# Dazhong Street Zhejiang Province, 323000, Lishui, China
| | - Zhengwei Chen
- Department of Gastrointestinal Surgery, Lishui City People's Hospital, 15# Dazhong Street Zhejiang Province, 323000, Lishui, China
| | - Xiaoming Pan
- Department of Gastrointestinal Surgery, Lishui City People's Hospital, 15# Dazhong Street Zhejiang Province, 323000, Lishui, China
| | - Ming Liu
- Department of Gastrointestinal Surgery, Lishui City People's Hospital, 15# Dazhong Street Zhejiang Province, 323000, Lishui, China
| | - Guoxiong Cheng
- Department of Gastrointestinal Surgery, Lishui City People's Hospital, 15# Dazhong Street Zhejiang Province, 323000, Lishui, China
| | - Jiaxin Li
- Department of Gastrointestinal Surgery, Lishui City People's Hospital, 15# Dazhong Street Zhejiang Province, 323000, Lishui, China
| | - Yijun Mei
- Department of Gastrointestinal Surgery, Lishui City People's Hospital, 15# Dazhong Street Zhejiang Province, 323000, Lishui, China.
| |
Collapse
|
9
|
Xie BB, Chang W, Wu K, Guo LL, Mei Y. [Application of three risk assessment methods to noise risk assessment in an automobile foundry enterprise]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2022; 40:271-275. [PMID: 35545593 DOI: 10.3760/cma.j.cn121094-20210109-00036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To explore the applicability of three different kinds of noise occupational health risk assessment methods to the occupational health risk assessment of noise exposed positions in an automobile foundry enterprise. Methods: In July 2020, the occupational-health risk assessment of noise-exposed positions was conducted by using the Guidelines for risk management of occupational noise hazard (guideline method) , the International Commission on Mining and Metals Guidelines for Occupational Health Risk Assessment (ICMM) method and the Occupational-health risk index method (index method) respectively, and the results were analyzed and compared. Results: Through the occupational health field investigation, the noise exposure level of the enterprise's main workstations was between 80.3 and 94.8 dB (A) , among which the noise of the posts of shaking-sand, cleaning and modeling was greater than 85 dB (A) ; The noise risk of each position was evaluated by the three methods, and the adjustment risk level was between 2 and 5 assessed using the guideline method, between 2 and 3 assessed using the index method, and 5 evaluated using the ICMM model. Conclusion: Each of the three risk assessment methods has its own advantages and disadvantages. The ICMM model has a large difference in value assignment, and values in the results are larger than expected. The evaluation results of the guideline method and the index method are consistent in some positions, there is certain subjectivity in the evaluation using the index method, and the guideline method is more objective.
Collapse
Affiliation(s)
- B B Xie
- School of Public Health, Wuhan University of Science and Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, WuHan 430065, China
| | - W Chang
- School of Public Health, Wuhan University of Science and Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, WuHan 430065, China
| | - K Wu
- Shiyan Prevention and Treatment Center for Occupational Disease, Shiyan 442000, China
| | - L L Guo
- Shiyan Prevention and Treatment Center for Occupational Disease, Shiyan 442000, China
| | - Y Mei
- School of Public Health, Wuhan University of Science and Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, WuHan 430065, China
| |
Collapse
|
10
|
Tang L, Xiao Q, Yin Y, Mei Y, Li J, Xu L, Gao H, Wang W. An enzyme-responsive and NIR-triggered lipid-polymer hybrid nanoplatform for synergistic photothermal/chemo cancer therapy. Biomater Sci 2022; 10:2370-2383. [PMID: 35383799 DOI: 10.1039/d2bm00216g] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A combination of photothermal therapy (PTT) and chemotherapy is an emerging therapeutic strategy with promising clinical prospects in cancer treatment. Despite the huge progress achieved in the past years, a number of obstacles still hamper the therapeutic efficacy of this synergistic modality such as uneven heat distribution, lack of targetability of anti-cancer agents and dosage-related side effects. Thus, developing a nanoplatform for targeted drug delivery against cancer is of great necessity. Herein, a lipid-polymer hybrid nanosystem (LP/ID) based on polyethyleneimine (PEI)-lecithin-polyethylene glycol (PEG) was fabricated to co-load indocyanine green (ICG) and dichloroacetate (DCA) for combined photothermal/chemotherapy. DCA and ICG were linked to the PEI backbone to form a dense hydrophobic core through amide bonds and electrostatic interactions, which increased the payload of DCA and ICG as well as achieved enzyme-responsive drug release because of the overexpressed amidase in tumor cells. Lecithin and DSPE-PEG2000 self-assembled around the hydrophobic complexes to obtain prolonged blood circulation and attenuated systemic toxicity of the hybrid nanosystem. The prepared LP/ID exhibited favourable stability in a physiological environment, good tumor imaging properties, and satisfactory photothermal/chemotherapeutic performance. Moreover, LP/ID could also enhance the cellular uptake and tumor retention capacity in comparison with free drug administration. Notably, by co-loading two therapeutic agents with different anti-cancer mechanisms, an obvious inhibitory effect on tumor growth was observed with negligible damage to normal tissues and organs because of the synergistic photothermal/chemotherapy effect, indicating the great potential of LP/ID as a robust nanoplatform for cancer treatment.
Collapse
Affiliation(s)
- Lu Tang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China.
| | - Qiaqia Xiao
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China.
| | - Yue Yin
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China.
| | - Yijun Mei
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China.
| | - Jing Li
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China.
| | - Lin Xu
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China.
| | - Hongbin Gao
- Department of Pharmacy, Baoshan Branch, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200444, P.R. China.
| | - Wei Wang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, Jiangsu, P.R. China.
| |
Collapse
|
11
|
Tang L, Fei Y, Su Y, Zhang A, Xiao Q, Mei Y, Su Y, Li Y, Li W, Wang T, Shen Y, Wang W. A neurovascular dual-targeting platelet-like bioinspired nanoplatform for ischemic stroke treatment. Acta Pharm Sin B 2022. [DOI: 10.1016/j.apsb.2022.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
12
|
Mei Y, Li Y, Nguyen H, Berman PR, Kuzmich A. Trapped Alkali-Metal Rydberg Qubit. Phys Rev Lett 2022; 128:123601. [PMID: 35394296 DOI: 10.1103/physrevlett.128.123601] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Accepted: 02/17/2022] [Indexed: 06/14/2023]
Abstract
Rydberg interactions of trapped alkali-metal atoms are used widely to facilitate quantum gate operations in quantum processors and repeaters. In most laboratory realizations using this protocol, the Rydberg states are repelled by the trapping laser fields, requiring that the fields be turned off during gate operations. Here we create a quasi-two-level system in a regime of Rydberg excitation blockade for a mesoscopic Rb ensemble of several hundred atoms confined in a magic-wavelength optical lattice. We observe many-body Rabi oscillations between the ground and collective Rydberg state. In addition we use Ramsey interference techniques to obtain the light shifts of both the lower and upper states of the collective qubit. Whereas the coupling producing the Rabi oscillations is enhanced by a factor of sqrt[N], there is no corresponding enhancement for the light shifts. We derive an effective two-level model which is in good agreement with our observations. Trapped Rydberg qubits and an effective two-level description are expected to have broad applicability for studies of quantum simulation and networking using collective encoding in ensembles of neutral atoms.
Collapse
Affiliation(s)
- Y Mei
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - Y Li
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - H Nguyen
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - P R Berman
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Kuzmich
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109, USA
| |
Collapse
|
13
|
Xie D, Li Y, Ma S, Yang X, Mei Y, Peng L, Lang Y, Chen A, Huang B, Chen Y, Huang X, Qian CN. FLASH Mechanisms Track (Oral Presentations) BIOLOGICAL EFFECT OF MURINE VENTRAL SKIN IRRADIATION WITH PULSED FLASH RADIOTHERAPY USING A CLINICAL LINAC. Phys Med 2022. [DOI: 10.1016/s1120-1797(22)01464-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
14
|
Yao Y, Li HR, Li Z, Mei Y, Ma H, Wu JB. [Neck musculoskeletal disorders and their influence factors among welders in an automobile factory]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2022; 40:28-32. [PMID: 35255558 DOI: 10.3760/cma.j.cn121094-20201207-00669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To explore the prevalence and risk factors of neck musculoskeletal diseases (MSDs) of welders among an automobile factory. Methods: In June 2019, a cluster random sampling method was used to select 677 electric welders from an automobile manufacturing plant in Shiyan City as the survey objects, and a questionnaire survey was conducted using the "Musculoskeletal Disorders Questionnaire" to analyze the prevalence and influencing factors of neck MSDs, and used logistic regression to analyze the relationship between the influencing factors and the prevalence of cervical MSDs. Results: The prevalence rate of MSDs in neck of welders was 54.8% (371/677) . The exposure rate of occupational factors, from high to low, were neckin a bent formord porsure was 71.6% (486/677) , repetitive head movements was 55.1% (373/677) , working in uncomfortable postures was 48.7% (330/677) and neck twisted was 46.8% (317/677) respectively. Sex, age, educational level, length of service, smoking, neck tilt, neck twist, working in uncomfortable posture and head repetitive movements were the risk factors of neck MSDs (P<0.05) . Multiple logistic regression analysis showed that, the main influencing factors of neck MSDs were sex, education level, age, length of service, smoking, neck tilt, working in uncomfortable posture (OR = 2.11, 2.03, 1.83, 1.21, 1.78, 1.90, 1.58, 95%CI: 1.28~3.48、1.47~2.81、1.33~2.52、1.03~1.41、1.22~2.60、1.28~2.83、1.11~2.27, P<0.05) , rest had protective effect on neck MSDs (OR= 0.38, 95%CI: 0.17~0.88, P<0.05) . Conclusion: Welders in automobile factory was highly exposed to occupational risk factors for neck MSDs. Occupational risk factors such as neck in a bent forward posture, working in an uncomfortable posture, prolonged siting, repetitive head movement should be the focus of intervention.
Collapse
Affiliation(s)
- Y Yao
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China Xiangyang Hospital of Integrated Traditional Chinese and Western Medicine, Xiangyang 441004, China
| | - H R Li
- Xiangyang Hospital of Integrated Traditional Chinese and Western Medicine, Xiangyang 441004, China
| | - Z Li
- Xiangyang Center for Disease Control and Prevention, Xiangyang 441022, China
| | - Y Mei
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - H Ma
- Xiangyang Hospital of Integrated Traditional Chinese and Western Medicine, Xiangyang 441004, China
| | - J B Wu
- Shiyan Institute for Occupational Disease Prevention and Treatment, Shiyan 442002, China
| |
Collapse
|
15
|
Tang L, Zhang A, Zhang Z, Zhao Q, Li J, Mei Y, Yin Y, Wang W. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy. Cancer Commun (Lond) 2022; 42:141-163. [PMID: 35001556 PMCID: PMC8822595 DOI: 10.1002/cac2.12255] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2021] [Revised: 09/24/2021] [Accepted: 12/30/2021] [Indexed: 12/12/2022] Open
Abstract
Phototherapy and immunotherapy in combination is regarded as the ideal therapeutic modality to treat both primary and metastatic tumors. Immunotherapy uses different immunological approaches to stimulate the immune system to identify tumor cells for targeted elimination. Phototherapy destroys the primary tumors by light irradiation, which induces a series of immune responses through triggering immunogenic cancer cell death. Therefore, when integrating immunotherapy with phototherapy, a novel anti-cancer strategy called photoimmunotherapy (PIT) is emerging. This synergistic treatment modality can not only enhance the effectiveness of both therapies but also overcome their inherent limitations, opening a new era for the current anti-cancer therapy. Recently, the advancement of nanomaterials affords a platform for PIT. From all these nanomaterials, inorganic nanomaterials stand out as ideal mediators in PIT due to their unique physiochemical properties. Inorganic nanomaterials can not only serve as carriers to transport immunomodulatory agents in immunotherapy owing to their excellent drug-loading capacity but also function as photothermal agents or photosensitizers in phototherapy because of their great optical characteristics. In this review, the recent advances of multifunctional inorganic nanomaterial-mediated drug delivery and their contributions to cancer PIT will be highlighted.
Collapse
Affiliation(s)
- Lu Tang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| | - Aining Zhang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| | - Ziyao Zhang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| | - Qingqing Zhao
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| | - Jing Li
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| | - Yijun Mei
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| | - Yue Yin
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| | - Wei Wang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.,National Medical Products Administration Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China
| |
Collapse
|
16
|
Tang L, Li J, Pan T, Yin Y, Mei Y, Xiao Q, Wang R, Yan Z, Wang W. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives. Am J Cancer Res 2022; 12:2290-2321. [PMID: 35265211 PMCID: PMC8899561 DOI: 10.7150/thno.69628] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Accepted: 02/05/2022] [Indexed: 12/02/2022] Open
Abstract
Despite the encouraging breakthroughs in medical development, cancer remains one of the principle causes of death and threatens human health around the world. Conventional treatment strategies often kill cancer cells at the expense of serious adverse effects or great pain, which yet is not able to achieve an effective cure. Therefore, it is urgent to seek for other novel anticancer approaches to improve the survival rate and life quality of cancer patients. During the past decades, nanotechnology has made tremendous progress in cancer therapy due to many advantages such as targeted drug delivery, decreased dosage-related adverse effects and prolonged drug circulation time. In the context of nanomedicine, carbon nanomaterials occupy very significant positions. Owing to their innate outstanding optical, thermal, electronic, and mechanic features, easy functionalization possibility and large surface for drug loading, carbon nanomaterials serve as not only drug carriers, but also multifunctional platforms to combine with diverse treatment and diagnosis modalities against cancer. Therefore, developing more carbon-based nanoplatforms plays a critical role in cancer theranostics and an update overview that summarizes the recent achievement of carbon nanomaterial-mediated anticancer theranostic approaches is of necessity. In this review, five typical and widely investigated carbon nanomaterials including graphene, graphdiyne, fullerene, carbon nanotubes and carbon quantum dots are introduced in detail from the aspect of treatment strategies based on both cancer cells and tumor microenvironment-involved therapeutic targets. Meanwhile, modern diagnostic methods and clinical translatability of carbon nanomaterials will be highlighted as well.
Collapse
|
17
|
Chen J, Wu JB, Wu K, Zheng JR, Mei LY, Mei Y. [Cumulative noise exposure and the risk of high-frequency hearing loss relationships]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2021; 39:919-924. [PMID: 35164421 DOI: 10.3760/cma.j.cn121094-20200619-00347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To explore the dose-response relationship between cumulative noise exposure and high-frequency hearing loss, and further to provide a basis for the control of occupational hazards of noise. Methods: A Meta-analysis of dose-response relationships was performed on the data of eligible literatures published in China from January 2000.1 to December 2019.12. Results: The initial combined Odds Ratio (OR) and its 95%CI in the Meta-analysis were 1.10 (1.08-1.12) . As the Begg's funnel plot and Egger's test indicated publication bias (t=5.97, P<0.01) , the Trim-and-Fill Method was used for OR value adjustment. The adjusted-OR was 1.09 (1.07-1.12) ; sensitivity analysis showed that the results of this Meta-analysis have high stability; subgroup analysis indicated that the ORs of the steady-state noise group and the non-steady-state noise group were 1.10 (1.08-1.12) and 1.14 (1.07-1.21) , the ORs of the old standard group and the new standard group were 1.10 (1.08-1.12) and 1.11 (1.00-1.24) , respectively. The nonlinear dose-response relationship curve demonstrated that the risk of high-frequency hearing loss increases rapidly after CNE reaches 95 dB (A) ·years. Conclusion: There is a definite dose-response relationship between CNE and high-frequency hearing loss, which can be used to predict the risk of high-frequency hearing loss in noisy workers.
Collapse
Affiliation(s)
- J Chen
- Shiyan Occupational Disease Prevention and Control Hospital, Shiyan 442000, China
| | - J B Wu
- Shiyan Occupational Disease Prevention and Control Hospital, Shiyan 442000, China
| | - K Wu
- Shiyan Occupational Disease Prevention and Control Hospital, Shiyan 442000, China
| | - J R Zheng
- Shiyan Occupational Disease Prevention and Control Hospital, Shiyan 442000, China
| | - L Y Mei
- Hubei Center for Disease Control and Prevention, Wuhan 430070, China
| | - Y Mei
- School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China
| |
Collapse
|
18
|
Tang L, Xiao Q, Mei Y, He S, Zhang Z, Wang R, Wang W. Insights on functionalized carbon nanotubes for cancer theranostics. J Nanobiotechnology 2021; 19:423. [PMID: 34915901 PMCID: PMC8679967 DOI: 10.1186/s12951-021-01174-y] [Citation(s) in RCA: 36] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2021] [Accepted: 12/01/2021] [Indexed: 12/13/2022] Open
Abstract
Despite the exciting breakthroughs in medical technology, cancer still accounts for one of the principle triggers of death and conventional therapeutic modalities often fail to attain an effective cure. Recently, nanobiotechnology has made huge advancement in cancer therapy with gigantic application potential because of their ability in achieving precise and controlled drug release, elevating drug solubility and reducing adverse effects. Carbon nanotubes (CNTs), one of the most promising carbon-related nanomaterials, have already achieved much success in biomedical field. Due to their excellent optical property, thermal and electronic conductivity, easy functionalization ability and high drug loading capacity, CNTs can be applied in a multifunctional way for cancer treatment and diagnosis. In this review, we will give an overview of the recent progress of CNT-based drug delivery systems in cancer theranostics, which emphasizes their targetability to intracellular components of tumor cells and extracellular elements in tumor microenvironment. Moreover, a detailed introduction on how CNTs penetrate inside the tumor cells to reach their sites of action and achieve the therapeutic effects, as well as their diagnostic applications will be highlighted. ![]()
Collapse
Affiliation(s)
- Lu Tang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Qiaqia Xiao
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Yijun Mei
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Shun He
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Ziyao Zhang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Ruotong Wang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Wei Wang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China. .,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
| |
Collapse
|
19
|
Tang L, Zhang A, Mei Y, Xiao Q, Xu X, Wang W. NIR Light-Triggered Chemo-Phototherapy by ICG Functionalized MWNTs for Synergistic Tumor-Targeted Delivery. Pharmaceutics 2021; 13:pharmaceutics13122145. [PMID: 34959425 PMCID: PMC8709090 DOI: 10.3390/pharmaceutics13122145] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Revised: 12/06/2021] [Accepted: 12/10/2021] [Indexed: 01/10/2023] Open
Abstract
The combinational application of photothermal therapy (PTT), chemotherapy, and nanotechnology is a booming therapeutic strategy for cancer treatment. Multi-walled carbon nanotube (MWNT) is often utilized as drug carrier in biomedical fields with excellent photothermal properties, and indocyanine green (ICG) is a near-infrared (NIR) dye approved by FDA. In addition, ICG is also a photothermal agent that can strongly absorb light energy for tumor ablation. Herein, we explored a synergistic strategy by connecting MWNT and a kind of ICG derivate ICG-NH2 through hyaluronic acid (HA) that possesses CD44 receptor targeting ability, which largely enhanced the PTT effect of both MWNT and ICG-NH2. To realize the synergistic therapeutic effect of chemotherapy and phototherapy, doxorubicin (DOX) was attached on the wall of MWNT via π-π interaction to obtain the final MWNT-HA-ICG/DOX nanocomplexes. Both in vitro and in vivo experiments verified the great therapeutic efficacy of MWNT-HA-ICG/DOX nanocomplexes, which was characterized by improved photothermal performance, strengthened cytotoxicity, and elevated tumor growth inhibition based on MCF-7 tumor models. Therefore, this synergistic strategy we report here might offer a new idea with promising application prospect for cancer treatment.
Collapse
Affiliation(s)
- Lu Tang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (L.T.); (A.Z.); (Y.M.); (Q.X.); (X.X.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Aining Zhang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (L.T.); (A.Z.); (Y.M.); (Q.X.); (X.X.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Yijun Mei
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (L.T.); (A.Z.); (Y.M.); (Q.X.); (X.X.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Qiaqia Xiao
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (L.T.); (A.Z.); (Y.M.); (Q.X.); (X.X.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Xiangting Xu
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (L.T.); (A.Z.); (Y.M.); (Q.X.); (X.X.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Wei Wang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (L.T.); (A.Z.); (Y.M.); (Q.X.); (X.X.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
- Correspondence:
| |
Collapse
|
20
|
Chen Z, Xu C, Pan X, Cheng G, Liu M, Li J, Mei Y. lncRNA DSCR8 mediates miR-137/Cdc42 to regulate gastric cancer cell proliferation, invasion, and cell cycle as a competitive endogenous RNA. Mol Ther Oncolytics 2021; 22:468-482. [PMID: 34553033 PMCID: PMC8430047 DOI: 10.1016/j.omto.2021.05.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/07/2020] [Accepted: 05/19/2021] [Indexed: 02/07/2023]
Abstract
lncRNA DSCR8 (Down syndrome critical region 8) is involved in progression of many cancers, but its specific role in gastric cancer (GC) is still unclear. Here, qRT-PCR detected upregulated expression of DSCR8 and Cdc42 and downregulated expression of miR-137 in GC. The protein expression level of Cdc42 in GC was upregulated as tested by western blot. Statistical analysis showed that DSCR8 was closely associated with some malignant clinicopathological features (such as tumor size, metastasis, and stage) in GC patients. Fluorescence in situ hybridization showed that DSCR8 was localized in the nucleus and cytoplasm. Dual-luciferase reporter gene, RNA immunoprecipitation, and biotin pull-down assays showed that DSCR8 could bind to miR-137 could bind to Cdc42. In vitro and in vivo assays showed that DSCR8 could promote proliferation, invasion, and the cycle of GC cells and inhibit cell apoptosis. In addition, a rescue experiment showed that DSCR8 regulated progression of GC cells via miR-137. Furthermore, DSCR8 regulated Cdc42 in GC cells by inhibiting miR-137. Taken together, these data indicated that DSCR8 could adsorb miR-137 to reduce its inhibitory effect on Cdc42 expression, thereby promoting the progression of GC cells and regulating the cell cycle. These results provide a novel direction for DSCR8 as a target of GC.
Collapse
Affiliation(s)
- Zhengwei Chen
- Department of Gastrointestinal Surgery, Lishui People's Hospital of Zhejiang Province, 15 Dazhong Street, Liandu District, Lishui City, Zhejiang 323000, China
| | - Chaobo Xu
- Department of Gastrointestinal Surgery, Lishui People's Hospital of Zhejiang Province, 15 Dazhong Street, Liandu District, Lishui City, Zhejiang 323000, China
| | - Xiaoming Pan
- Department of Gastrointestinal Surgery, Lishui People's Hospital of Zhejiang Province, 15 Dazhong Street, Liandu District, Lishui City, Zhejiang 323000, China
| | - Guoxiong Cheng
- Department of Gastrointestinal Surgery, Lishui People's Hospital of Zhejiang Province, 15 Dazhong Street, Liandu District, Lishui City, Zhejiang 323000, China
| | - Ming Liu
- Department of Gastrointestinal Surgery, Lishui People's Hospital of Zhejiang Province, 15 Dazhong Street, Liandu District, Lishui City, Zhejiang 323000, China
| | - Jiaxin Li
- Department of Gastrointestinal Surgery, Lishui People's Hospital of Zhejiang Province, 15 Dazhong Street, Liandu District, Lishui City, Zhejiang 323000, China
| | - Yijun Mei
- Department of Gastrointestinal Surgery, Lishui People's Hospital of Zhejiang Province, 15 Dazhong Street, Liandu District, Lishui City, Zhejiang 323000, China
| |
Collapse
|
21
|
Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin Y, Xu Y, Shao J, Wang W, Cai Z. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy. Int J Nanomedicine 2021; 16:5811-5829. [PMID: 34471353 PMCID: PMC8403563 DOI: 10.2147/ijn.s321416] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 08/14/2021] [Indexed: 12/24/2022] Open
Abstract
Advanced research has revealed the crucial role of tumor microenvironment (TME) in tumorigenesis. TME consists of a complicated network with a variety of cell types including endothelial cells, pericytes, immune cells, cancer-associated fibroblasts (CAFs), cancer stem cells (CSCs) as well as the extracellular matrix (ECM). The TME-constituting cells interact with the cancerous cells through plenty of signaling mechanisms and pathways in a dynamical way, participating in tumor initiation, progression, metastasis, and response to therapies. Hence, TME is becoming an attractive therapeutic target in cancer treatment, exhibiting potential research interest and clinical benefits. Presently, the novel nanotechnology applied in TME regulation has made huge progress. The nanoparticles (NPs) can be designed as demand to precisely target TME components and to inhibit tumor progression through TME modulation. Moreover, nanotechnology-mediated drug delivery possesses many advantages including prolonged circulation time, enhanced bioavailability and decreased toxicity over traditional therapeutic modality. In this review, update information on TME remodeling through NPs-based targeted drug delivery strategies for anticancer therapy is summarized.
Collapse
Affiliation(s)
- Lu Tang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Yijun Mei
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Yan Shen
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Shun He
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Qiaqia Xiao
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Yue Yin
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Yonggang Xu
- Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China
| | - Jie Shao
- Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China
| | - Wei Wang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.,NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, 210009, People's Republic of China
| | - Zihao Cai
- Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, People's Republic of China
| |
Collapse
|
22
|
He X, Sun Z, Ma K, Mei Y. [1-deoxynojirimycin alleviates liver fibrosis induced by type 2 diabetes in mice]. Nan Fang Yi Ke Da Xue Xue Bao 2021; 41:1342-1349. [PMID: 34658348 DOI: 10.12122/j.issn.1673-4254.2021.09.08] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To investigate the effect of 1-deoxynojirimycin (DNJ) for improving diabetic liver fibrosis and explore the underlying mechanism. METHODS Mouse models of type 2 diabetes were established in 10 Kunming mice by high-fat diet feeding for 8 weeks and intraperitoneal injection of STZ, with 5 mice receiving intraperitoneal injection of citrate buffer solution with normal feeding as the control group. The mouse models were randomized into two groups (n=5) for further highfat feeding (model group) and additional treatment with 10% DNJ in drinking water (200 mg · kg-1 per day; DNJ group) for 8 weeks. The mice were monitored for changes in body weight (BW), blood glucose, serum total cholesterol (TC), triglyceride (TG) and superoxide dismutase (SOD) levels. The pathological changes in the liver tissue were observed using HE and Sirius Red staining, and the solubility of collagens in the liver tissues was determined. The expression levels of MCP-1, TNF-α, IL-1β and TGF-β1 mRNA were detected with real-time PCR, and the protein expressions of α-SMA and collagen2 (ColA2) were determined with Western blotting. In the in vitro experiment, mouse fibroblasts L929 cells were pretreated with DNJ (10 μg/ mL) or PBS for 30 min followed by culture in high-glucose medium for 24 h, and the level of ROS production was measured using dihydroethidium (DHE) staining. RESULTS In the mouse model of type 2 diabetes, DNJ treatment significantly lowered serum level of glucose, TC, and TG (P < 0.05) and increased serum SOD activity (P < 0.05). DNJ obviously attenuated liver fibrosis in the diabetic mice, as shown by alleviated cross-linking of collagens and reduced contents of pepsin-solubilized collagen (PSC) and total collagen (P < 0.05). DNJ treatment also significantly reduced the overexpression of the proinflammatory cytokines and fibrosis-related cytokines induced by diabetes (P < 0.05). In L929 cells exposed to high glucose, pretreatment with DNJ significantly lowered the intensity of red fluorescence in DHE staining. CONCLUSION DNJ can attenuate type 2 diabetes-induced liver fibrosis in mice through its hypoglycemic, anti-inflammatory and anti-oxidative effects.
Collapse
Affiliation(s)
- X He
- School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China
| | - Z Sun
- School of Stomatology, Zhengzhou University, Zhengzhou 450052, China
| | - K Ma
- School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China
| | - Y Mei
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China
| |
Collapse
|
23
|
Liu H, Mei Y, Zhao Q, Zhang A, Tang L, Gao H, Wang W. Black Phosphorus, an Emerging Versatile Nanoplatform for Cancer Immunotherapy. Pharmaceutics 2021; 13:1344. [PMID: 34575419 PMCID: PMC8466662 DOI: 10.3390/pharmaceutics13091344] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2021] [Revised: 08/15/2021] [Accepted: 08/24/2021] [Indexed: 12/13/2022] Open
Abstract
Black phosphorus (BP) is one of the emerging versatile nanomaterials with outstanding biocompatibility and biodegradability, exhibiting great potential as a promising inorganic nanomaterial in the biomedical field. BP nanomaterials possess excellent ability for valid bio-conjugation and molecular loading in anticancer therapy. Generally, BP nanomaterials can be classified into BP nanosheets (BPNSs) and BP quantum dots (BPQDs), both of which can be synthesized through various preparation routes. In addition, BP nanomaterials can be applied as photothermal agents (PTA) for the photothermal therapy (PTT) due to their high photothermal conversion efficiency and larger extinction coefficients. The generated local hyperpyrexia leads to thermal elimination of tumor. Besides, BP nanomaterials are capable of producing singlet oxygen, which enable its application as a photosensitizer for photodynamic therapy (PDT). Moreover, BP nanomaterials can be oxidized and degraded to nontoxic phosphonates and phosphate under physiological conditions, improving their safety as a nano drug carrier in cancer therapy. Recently, it has been reported that BP-based PTT is capable of activating immune responses and alleviating the immunosuppressive tumor microenvironment by detection of T lymphocytes and various immunocytokines, indicating that BP-based nanocomposites not only serve as effective PTAs to ablate large solid tumors but also function as an immunomodulation agent to eliminate discrete tumorlets. Therefore, BP-mediated immunotherapy would provide more possibilities for synergistic cancer treatment.
Collapse
Affiliation(s)
- Hao Liu
- Department of Pharmacy, Guangdong Food and Drug Vocational College, Guangzhou 510520, China;
| | - Yijun Mei
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (Y.M.); (Q.Z.); (A.Z.); (L.T.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Qingqing Zhao
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (Y.M.); (Q.Z.); (A.Z.); (L.T.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Aining Zhang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (Y.M.); (Q.Z.); (A.Z.); (L.T.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Lu Tang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (Y.M.); (Q.Z.); (A.Z.); (L.T.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| | - Hongbin Gao
- Department of Pharmacy, Baoshan Branch, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200444, China
| | - Wei Wang
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; (Y.M.); (Q.Z.); (A.Z.); (L.T.)
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing 210009, China
| |
Collapse
|
24
|
Gu YY, Mei Y, Su WT, Han J. [Determination of Methoxyacetic acid in urine by pre-column derivatization-liquid-liquid microextraction coupled with gas chromatography]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2021; 39:602-605. [PMID: 34488270 DOI: 10.3760/cma.j.cn121094-20200603-00317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Objective: To establish a method for determining methoxyacetic acid in urine by pre-column derivatization-liquid-liquid microextraction coupled with gas chromatography (GC) . Methods: Phosphate buffer solution, tert-butoxyacetic acid (internal standard) and pentafluorobenzyl bromide (derivative) were added to the urine sample. After derived in a water bath at 90 ℃ for 40 min, the mixture was cooled and filtered, then the dichloromethane was used as an extractant. After being shaken and centrifuged, the lower organic phase was sucked and injected into a gas chromatograph, separated by a DB-5 capillary column, and detected by an ECD detector. Results: The linear range of the method was 0.6~60.0 mg/L with the correlation coefficients (r) above 0.999. The average recovery was76.6%~110.7%, the inter-day precision was 8.00%~8.82%, and the detection limit was 0.13 mg/L. Conclusion: The method was founded to be high sensitivity, low organic reagent usage and green. So it is suitable for the detection of methoxyacetic acid in urine of occupational exposure to ethylene glycol monomethyl ether.
Collapse
Affiliation(s)
- Y Y Gu
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China College of Resource and Environmental Engineering of Science and Technology, Wuhan 430065, China Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan 430065, China
| | - Y Mei
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan 430065, China
| | - W T Su
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan 430065, China
| | - J Han
- College of Resource and Environmental Engineering of Science and Technology, Wuhan 430065, China
| |
Collapse
|
25
|
Shen H, Mei Y, Zhang K, Xu X. The Effect of Vitamin D Supplementation on Clinical Outcomes for Critically Ill Patients: A Systemic Review and Meta-Analysis of Randomized Clinical Trials. Front Nutr 2021; 8:664940. [PMID: 34017850 PMCID: PMC8129506 DOI: 10.3389/fnut.2021.664940] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2021] [Accepted: 03/22/2021] [Indexed: 12/19/2022] Open
Abstract
Purpose: Vitamin D deficiency is a common scenario in critically ill patients and has been proven to be associated with poor outcomes. However, the effect of vitamin D supplementation for critically ill patients remains controversial. Thus, we conducted a meta-analysis to evaluate the effect of vitamin D supplementation among critically ill patients. Methods: Electronic databases PubMed, Embase, Scopus, and the Cochrane Library were searched for eligible randomized controlled trials between 2000 and January 2021. The primary outcome was overall mortality, and the secondary ones were the length of intensive care unit stay, the length of hospital stay, as well as the duration of mechanical ventilation. Subgroup analyses were performed to explore the treatment effect by type of admission, route of administration, dose of supplemented vitamin D, and the degree of vitamin D deficiency. Results: A total of 14 studies involving 2,324 patients were finally included. No effect on overall mortality was found between vitamin D supplementation and control group [odds ratio (OR), 0.73; 95% CI, 0.52-1.03; I 2 = 28%]. The vitamin D supplementation reduced the length of intensive care unit stay [mean difference (MD), -2.25; 95% CI, -4.07 to -0.44, I 2 = 71%] and duration of mechanical ventilation (MD, -3.47; 95% CI, -6.37 to -0.57, I 2 = 88%). In the subgroup analyses, the vitamin D supplementation for surgical patients (OR, 0.67; 95% CI, 0.47-0.94; I 2 = 0%) or through parenteral way (OR, 0.42; 95% CI, 0.22-0.82, I 2 = 0%) was associated with reduced mortality. Conclusion: In critically ill patients, the supplementation of vitamin D has no effect on overall mortality compared to placebo but may decrease the length of intensive care unit stay and mechanical ventilation. Further trials are necessary to confirm our findings.
Collapse
Affiliation(s)
- Hejuan Shen
- Department of General Surgery, Lishui People's Hospital, Lishui, China.,Department of General Surgery, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, China
| | - Yijun Mei
- Department of General Surgery, Lishui People's Hospital, Lishui, China.,Department of General Surgery, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, China
| | - Kai Zhang
- Department of Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Xiaoya Xu
- Department of General Surgery, Lishui People's Hospital, Lishui, China.,Department of General Surgery, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, China
| |
Collapse
|
26
|
Adams DQ, Alduino C, Alfonso K, Avignone FT, Azzolini O, Bari G, Bellini F, Benato G, Biassoni M, Branca A, Brofferio C, Bucci C, Camilleri J, Caminata A, Campani A, Canonica L, Cao XG, Capelli S, Cappelli L, Cardani L, Carniti P, Casali N, Chiesa D, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick RJ, D'Addabbo A, Dafinei I, Davis CJ, Dell'Oro S, Di Domizio S, Dompè V, Fang DQ, Fantini G, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fu SH, Fujikawa BK, Giachero A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Han K, Heeger KM, Huang RG, Huang HZ, Johnston J, Keppel G, Kolomensky YG, Ligi C, Ma L, Ma YG, Marini L, Maruyama RH, Mayer D, Mei Y, Moggi N, Morganti S, Napolitano T, Nastasi M, Nikkel J, Nones C, Norman EB, Nucciotti A, Nutini I, O'Donnell T, Ouellet JL, Pagan S, Pagliarone CE, Pagnanini L, Pallavicini M, Pattavina L, Pavan M, Pessina G, Pettinacci V, Pira C, Pirro S, Pozzi S, Previtali E, Puiu A, Rosenfeld C, Rusconi C, Sakai M, Sangiorgio S, Schmidt B, Scielzo ND, Sharma V, Singh V, Sisti M, Speller D, Surukuchi PT, Taffarello L, Terranova F, Tomei C, Vetter KJ, Vignati M, Wagaarachchi SL, Wang BS, Welliver B, Wilson J, Wilson K, Winslow LA, Zimmermann S, Zucchelli S. Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE. Phys Rev Lett 2021; 126:171801. [PMID: 33988435 DOI: 10.1103/physrevlett.126.171801] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Revised: 03/10/2021] [Accepted: 03/11/2021] [Indexed: 06/12/2023]
Abstract
We measured two-neutrino double beta decay of ^{130}Te using an exposure of 300.7 kg yr accumulated with the CUORE detector. Using a Bayesian analysis to fit simulated spectra to experimental data, it was possible to disentangle all the major background sources and precisely measure the two-neutrino contribution. The half-life is in agreement with past measurements with a strongly reduced uncertainty: T_{1/2}^{2ν}=7.71_{-0.06}^{+0.08}(stat)_{-0.15}^{+0.12}(syst)×10^{20} yr. This measurement is the most precise determination of the ^{130}Te 2νββ decay half-life to date.
Collapse
Affiliation(s)
- D Q Adams
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Alduino
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Alfonso
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - O Azzolini
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - G Bari
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - F Bellini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - G Benato
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Biassoni
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A Branca
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Brofferio
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Bucci
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - J Camilleri
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - A Caminata
- INFN-Sezione di Genova, Genova I-16146, Italy
| | - A Campani
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Canonica
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - X G Cao
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - S Capelli
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Cappelli
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cardani
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - P Carniti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - N Casali
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - D Chiesa
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Clemenza
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Copello
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - C Cosmelli
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - O Cremonesi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - R J Creswick
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A D'Addabbo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - I Dafinei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - C J Davis
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - S Dell'Oro
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Di Domizio
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - V Dompè
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - D Q Fang
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - G Fantini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - M Faverzani
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Ferri
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - F Ferroni
- INFN-Sezione di Roma, Roma I-00185, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - E Fiorini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M A Franceschi
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - S J Freedman
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S H Fu
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - B K Fujikawa
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Giachero
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Gironi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Giuliani
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - P Gorla
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - C Gotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - T D Gutierrez
- Physics Department, California Polytechnic State University, San Luis Obispo, California 93407, USA
| | - K Han
- INPAC and School of Physics and Astronomy, Shanghai Jiao Tong University; Shanghai Laboratory for Particle Physics and Cosmology, Shanghai 200240, China
| | - K M Heeger
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - R G Huang
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - H Z Huang
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - J Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - G Keppel
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - Yu G Kolomensky
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - C Ligi
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - L Ma
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - Y G Ma
- Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - L Marini
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R H Maruyama
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - D Mayer
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Y Mei
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N Moggi
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum-Università di Bologna, Bologna I-40127, Italy
| | - S Morganti
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - T Napolitano
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - M Nastasi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - J Nikkel
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C Nones
- IRFU, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France
| | - E B Norman
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - A Nucciotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - I Nutini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - T O'Donnell
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - J L Ouellet
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Pagan
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C E Pagliarone
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - L Pagnanini
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - M Pallavicini
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Pattavina
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Pavan
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - G Pessina
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | | | - C Pira
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - S Pirro
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - S Pozzi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Previtali
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Puiu
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - C Rosenfeld
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Rusconi
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Sakai
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - S Sangiorgio
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - B Schmidt
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N D Scielzo
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - V Sharma
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - V Singh
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Sisti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - D Speller
- Department of Physics and Astronomy, The Johns Hopkins University, 3400 North Charles Street Baltimore, Maryland 21211, USA
| | - P T Surukuchi
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | | | - F Terranova
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Tomei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - K J Vetter
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Vignati
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S L Wagaarachchi
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B S Wang
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - B Welliver
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - L A Winslow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Zimmermann
- Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Zucchelli
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum-Università di Bologna, Bologna I-40127, Italy
| |
Collapse
|
27
|
Mei Y, Tang L, Xiao Q, Zhang Z, Zhang Z, Zang J, Zhou J, Wang Y, Wang W, Ren M. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy. J Mater Chem B 2021; 9:612-633. [PMID: 33306079 DOI: 10.1039/d0tb02139c] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
rHDL is a synthesized drug delivery nanoplatform exhibiting excellent biocompatibility, which possesses most of the advantages of HDL. rHDL shows almost no toxicity and can be degraded to non-toxic substances in vivo. The severe limitation of the application of various antitumor agents is mainly due to their low bioavailability, high toxicity, poor stability, etc. Favorably, antitumor drug-loaded rHDL nanoparticles (NPs), which are known as an important drug delivery system (DDS), help to change the situation a lot. This DDS shows an outstanding active-targeting ability towards tumor cells and improves the therapeutic effect during antitumor treatment while overcoming the shortcomings mentioned above. In the following text, we will mainly focus on the various applications of rHDL in tumor targeted therapy by describing the properties, preparation, receptor active-targeting ability and antitumor effects of antineoplastic drug-loaded rHDL NPs.
Collapse
Affiliation(s)
- Yijun Mei
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Chen HC, Peng SJ, Gao HM, Su WT, Mei Y, Yi GL. [Determination of n-butyl alcohol in urine by headspace solid-phase microextraction coupled with gas chromatography]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2021; 38:932-935. [PMID: 33406560 DOI: 10.3760/cma.j.cn121094-20200102-00003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To establish a headspace solid phase microextraction-gas chromatography method for determination of n-Butyl alcohol in urine. Methods: In October 2019, the n-butyl alcohol in urine was extracted with a polydimethylsiloxane/divinylbenzene (PDMS/DVB) solid-phase microextraction head. The conditions of salt amount, extraction temperature, extraction time and desorption time were optimized. The separation was performed on HP-5 (30 m×0.32 mm×0.25 μm) capillary column and detected with flame ionization detector. The quantification was based on the external standard curve. Results: The linear relationship of n-butyl alcohol in urine was good in the range of 0.04-3.00 mg/L, the correlation coefficient was 0.999, the detection limit of the method was 0.04 mg/L, the recovery was 77.4%-102.8%, the intra-run precision was 3.67%-8.11%, and the inter-assay precision was 4.94%-6.90%. Conclusion: The method has simple operation, high concentration efficiency and high sensitivity, and it is suitable for the determination of n-butyl alcohol in urine of occupational exposure to n-butyl alcohol.
Collapse
Affiliation(s)
- H C Chen
- Key Laboratory of Occupational Hazards Identification and Control in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - S J Peng
- Key Laboratory of Occupational Hazards Identification and Control in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - H M Gao
- Key Laboratory of Occupational Hazards Identification and Control in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - W T Su
- Key Laboratory of Occupational Hazards Identification and Control in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - Y Mei
- Key Laboratory of Occupational Hazards Identification and Control in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - G L Yi
- Wuhan Prevention and Treatment Center for Occupational Disease, Wuhan 430015, China
| |
Collapse
|
29
|
Gu YY, Mei Y, Nie MH, Sheng XG, Fang RD, Su WT, Han J. [Determination of metabolites of styrene in urine by dispersive liquid-liquid microextraction coupled with high performance liquid chromatography]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2020; 38:689-692. [PMID: 33036535 DOI: 10.3760/cma.j.cn121094-20191010-00469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To establish a method for the determination of mandelic acid and phenylglyoxylic acid in the urine of styrene by dispersive liquid-liquid microextraction-high coupled with high performance liquid chromatography. Methods: N-octanol was used as an extractant and ethanol was used as a dispersing agent. The phenylglycolic acid and phenylglyoxylic acid in the urine were extracted, and the upper liquid was taken after vortexing and centrifuged, and then was injected into HPLC for analysis. Results: The linear correlation coefficient of the concentration of phenylglycolic acid in the range of 0~10.0 mg/L was greater than 0.999. The detection limit of the method was 9.9 μg/L, the recovery rates were 86.1%~101.6%. The intraday RSDs of the method were 1.07%~3.76%, and the interday RSDs were 1.24%~3.33%. The linear correlation coefficient of phenylglyoxylic acid in the range of 0.0~2.0 mg/L is greater than 0.999. The detection limit of the method was 2.6 μg/L, the recovery rates were 88.8%~100.3%. The intraday RSDs of the method were 1.02%~ 3.17%, and the interday RSDs were 1.59%~2.41%. Conclusion: The method has low detection limit, high enrichment ratio and good sensitivity, and is suitable for determination of phenylglycolic acid and phenylglyoxylic acid in urine of occupational exposure to styrene.
Collapse
Affiliation(s)
- Y Y Gu
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China ; College of Resource and Environmental Engineering of Science and Technology, Wuhan 430065, China ; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan 430065, China
| | - Y Mei
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China ; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan 430065, China
| | - M H Nie
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - X G Sheng
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - R D Fang
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - W T Su
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - J Han
- College of Resource and Environmental Engineering of Science and Technology, Wuhan 430065, China
| |
Collapse
|
30
|
Ren YM, Mei Y, Fang RD. [Determination of nickel in urine by ultrasonic-assisted ionic liquid microextraction-graphite furnace atomic absorption spectrometry]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2020; 38:767-769. [PMID: 33142384 DOI: 10.3760/cma.j.cn121094-20191010-00483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To set up a new method to determine the nickel of urine in urine using dispersive liquid-liquid microextraction (DLLME) coupled with graphite furnace atomic absorption spectrometry (GFAAS) . Methods: From September 2018 to September 2019, the methanol, pyrrolidine dithiocarbamate and ionic liquid 1-hexyl-3-methyl-imidazolium hexafluorophosphate were used as dispersive solvent, the chelating agent and extraction solvent for the preconcentration of nickel, respectively. After adding into buffer solution of pH 9, ultrasonic dissolving for 10 minutes, centrifugal separation and then discarding the supernatant, the precipitate was saved. Dissolving the precipitate by methanol, mixing thoroughly on a vortex mixer, the 15 μl of the mixed solution was used for determination by graphite furnace atomic absorption spectrometry. Results: The linear correlation coefficient of urine nickel concentration in the range of 2.0-10.0 μg/L, r=0.999, with the detection limitation of 0.43 μg/L. The recovery rate and the relative standard deviations were 95.6%-103.7% and 2.53%-4.82%, respectively. Conclusion: The method, which has low detection limit, high recovery rate and good precision, is suitable for the determination of nickel in urine for the occupational populations exposure to nickel and non-occupational exposure.
Collapse
Affiliation(s)
- Y M Ren
- Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - Y Mei
- Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - R D Fang
- Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| |
Collapse
|
31
|
Wang Y, Gu YY, Fang RD, Mei Y. [Determination of manganese in human urine by dispersive ionic liquid-liquid microextraction-graphite furnace atomic absorption spectrometry]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2020; 38:216-218. [PMID: 32306698 DOI: 10.3760/cma.j.cn121094-20190718-00313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To establish a method for the determination of manganese in urine with graphite furnace atomic absorption spectrometry (GFAAS) by using ionic liquid microextraction. Methods: The ethanol, 8-hydroxyquinoline and ionic liquid 1-octyl-3-methyl-imidazolium hexafluorophosphate were used as dispersive solvent, chelating agent and extraction solvent respectively, for the preconcentration of manganese. After the optimal extraction conditions were optimized by single factor rotations, evaluate the performance indicators such as methodological precision, accuracy, and detection limit. Results: The linear range of urine manganese was 0.0-1.6 μg/L, and the correlation coefficient of standard curve line was 0.992, the detection limit was 0.03 μg/L, the recovery of sample spiked was 84.90%-96.50%, and the relative standard deviation was 0.36%-1.84%. Conclusion: The method has the advantages of low detection limit, high recovery rate and high sensitivity. It is suitable for the determination of manganese in urine samples from occupational exposure populations and the general population.
Collapse
Affiliation(s)
- Y Wang
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China; Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan 430064, China
| | - Y Y Gu
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - R D Fang
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - Y Mei
- School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| |
Collapse
|
32
|
Lin P, Zhu S, Huang Y, Li L, Tao J, Lei T, Song J, Liu D, Chen L, Shi Y, Jiang S, Liu Q, Xie J, Chen H, Duan Y, Xia Y, Zhou Y, Mei Y, Zhou X, Wu J, Fang M, Meng Z, Li H. Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions. Br J Dermatol 2020; 183:190-192. [PMID: 32255197 PMCID: PMC7262186 DOI: 10.1111/bjd.19089] [Citation(s) in RCA: 119] [Impact Index Per Article: 29.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- P Lin
- Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.,Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.,National Clinical Research Center for Skin and Immune Diseases, Beijing, China
| | - S Zhu
- Department of Biostatistics, Peking University First Hospital, Beijing, China
| | - Y Huang
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada
| | - L Li
- Department of Infection Management, Peking University First Hospital, Beijing, China
| | - J Tao
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - T Lei
- Department of Dermatology and Venerology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
| | - J Song
- Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
| | - D Liu
- Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - L Chen
- Department of Dermatology, Wuhan First Hospital, Wuhan, Hubei, China
| | - Y Shi
- Department of Dermatology and Venerology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
| | - S Jiang
- Department of Dermatology and Venerology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China
| | - Q Liu
- Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
| | - J Xie
- Department of Dermatology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
| | - H Chen
- Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Duan
- Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Xia
- Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Zhou
- Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Mei
- Department of Dermatology, Wuhan First Hospital, Wuhan, Hubei, China
| | - X Zhou
- Department of Dermatology, Wuhan First Hospital, Wuhan, Hubei, China
| | - J Wu
- Department of Dermatology, Wuhan First Hospital, Wuhan, Hubei, China
| | - M Fang
- Department of Dermatology, Xiaogan Central Hospital, Xiaogan, Hubei, China
| | - Z Meng
- Department of Dermatology, Renmin Hospital Hubei University of Medicine, Shiyan, Hubei, China
| | - H Li
- Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.,Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.,National Clinical Research Center for Skin and Immune Diseases, Beijing, China
| |
Collapse
|
33
|
Adams DQ, Alduino C, Alfonso K, Avignone FT, Azzolini O, Bari G, Bellini F, Benato G, Biassoni M, Branca A, Brofferio C, Bucci C, Caminata A, Campani A, Canonica L, Cao XG, Capelli S, Cappelli L, Cardani L, Carniti P, Casali N, Chiesa D, Chott N, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick RJ, D'Addabbo A, D'Aguanno D, Dafinei I, Davis CJ, Dell'Oro S, Di Domizio S, Dompè V, Fang DQ, Fantini G, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fujikawa BK, Giachero A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Han K, Heeger KM, Huang RG, Huang HZ, Johnston J, Keppel G, Kolomensky YG, Ligi C, Ma YG, Ma L, Marini L, Maruyama RH, Mei Y, Moggi N, Morganti S, Napolitano T, Nastasi M, Nikkel J, Nones C, Norman EB, Novati V, Nucciotti A, Nutini I, O'Donnell T, Ouellet JL, Pagliarone CE, Pagnanini L, Pallavicini M, Pattavina L, Pavan M, Pessina G, Pettinacci V, Pira C, Pirro S, Pozzi S, Previtali E, Puiu A, Rosenfeld C, Rusconi C, Sakai M, Sangiorgio S, Schmidt B, Scielzo ND, Sharma V, Singh V, Sisti M, Speller D, Surukuchi PT, Taffarello L, Terranova F, Tomei C, Vignati M, Wagaarachchi SL, Wang BS, Welliver B, Wilson J, Wilson K, Winslow LA, Zanotti L, Zimmermann S, Zucchelli S. Improved Limit on Neutrinoless Double-Beta Decay in ^{130} Te with CUORE. Phys Rev Lett 2020; 124:122501. [PMID: 32281829 DOI: 10.1103/physrevlett.124.122501] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2019] [Revised: 02/11/2020] [Accepted: 02/27/2020] [Indexed: 06/11/2023]
Abstract
We report new results from the search for neutrinoless double-beta decay in ^{130} Te with the CUORE detector. This search benefits from a fourfold increase in exposure, lower trigger thresholds, and analysis improvements relative to our previous results. We observe a background of (1.38±0.07)×10^{-2} counts/(keV kg yr)) in the 0νββ decay region of interest and, with a total exposure of 372.5 kg yr, we attain a median exclusion sensitivity of 1.7×10^{25} yr. We find no evidence for 0νββ decay and set a 90% credibility interval Bayesian lower limit of 3.2×10^{25} yr on the ^{130} Te half-life for this process. In the hypothesis that 0νββ decay is mediated by light Majorana neutrinos, this results in an upper limit on the effective Majorana mass of 75-350 meV, depending on the nuclear matrix elements used.
Collapse
Affiliation(s)
- D Q Adams
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Alduino
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Alfonso
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - O Azzolini
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - G Bari
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - F Bellini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - G Benato
- Department of Physics, University of California, Berkeley, California 94720, USA
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Biassoni
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A Branca
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Brofferio
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Bucci
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - A Caminata
- INFN-Sezione di Genova, Genova I-16146, Italy
| | - A Campani
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Canonica
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - X G Cao
- Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - S Capelli
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Cappelli
- Department of Physics, University of California, Berkeley, California 94720, USA
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cardani
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - P Carniti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - N Casali
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - D Chiesa
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - N Chott
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Clemenza
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Copello
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - C Cosmelli
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - O Cremonesi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - R J Creswick
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A D'Addabbo
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - D D'Aguanno
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - I Dafinei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - C J Davis
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - S Dell'Oro
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - S Di Domizio
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - V Dompè
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - D Q Fang
- Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - G Fantini
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - M Faverzani
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Ferri
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - F Ferroni
- INFN-Sezione di Roma, Roma I-00185, Italy
- Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - E Fiorini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M A Franceschi
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - S J Freedman
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B K Fujikawa
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Giachero
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Gironi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Giuliani
- CSNSM, Univ. Paris-Sud, CNRS/IN2P3, Université Paris-Saclay, 91405 Orsay, France
| | - P Gorla
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - C Gotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - T D Gutierrez
- Physics Department, California Polytechnic State University, San Luis Obispo, California 93407, USA
| | - K Han
- INPAC and School of Physics and Astronomy, Shanghai Jiao Tong University; Shanghai Laboratory for Particle Physics and Cosmology, Shanghai 200240, China
| | - K M Heeger
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - R G Huang
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - H Z Huang
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - J Johnston
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - G Keppel
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - Yu G Kolomensky
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - C Ligi
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - Y G Ma
- Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Institute of Modern Physics, Fudan University, Shanghai 200433, China
| | - L Ma
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - L Marini
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R H Maruyama
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - Y Mei
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N Moggi
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum-Università di Bologna, Bologna I-40127, Italy
| | - S Morganti
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - T Napolitano
- INFN-Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - M Nastasi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - J Nikkel
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C Nones
- Service de Physique des Particules, CEA/Saclay, 91191 Gif-sur-Yvette, France
| | - E B Norman
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - V Novati
- CSNSM, Univ. Paris-Sud, CNRS/IN2P3, Universit Paris-Saclay, 91405 Orsay, France
| | - A Nucciotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - I Nutini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - T O'Donnell
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - J L Ouellet
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - C E Pagliarone
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - L Pagnanini
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Pallavicini
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - L Pattavina
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Pavan
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - G Pessina
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | | | - C Pira
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - S Pirro
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - S Pozzi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Previtali
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Puiu
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Rosenfeld
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Rusconi
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Sakai
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - S Sangiorgio
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - B Schmidt
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N D Scielzo
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - V Sharma
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - V Singh
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Sisti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - D Speller
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - P T Surukuchi
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | | | - F Terranova
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Tomei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - M Vignati
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S L Wagaarachchi
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B S Wang
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - B Welliver
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - L A Winslow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - L Zanotti
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Zimmermann
- Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Zucchelli
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum-Università di Bologna, Bologna I-40127, Italy
| |
Collapse
|
34
|
Cheng G, Mei Y, Pan X, Liu M, Wu S. Expression of HER2/c-erbB-2, EGFR Protein in Gastric Carcinoma and its Clinical Significance. Open Life Sci 2019; 14:119-125. [PMID: 33817143 PMCID: PMC7874756 DOI: 10.1515/biol-2019-0013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2018] [Accepted: 10/08/2018] [Indexed: 01/18/2023] Open
Abstract
Objective To investigate the HER2/c-erbB-2, epidermal growth factor receptor (EGFR) protein expression in gastric cancer and association with patients’ clinical pathology characteristics and prognosis. Methods HER2/c-erbB-2 and EGFR protein expression was examined by immunohistochemical assay in gastric cancer tissue and corresponding paired normal gastric tissue of 67 patients of gastric carcinoma. The HER2/c-erbB-2, EGFR protein positive expression rate in cancer tissue and normal gastric tissue were compared. The correlation between HER2/c-erbB-2, EGFR protein positive expression and patients’ clinical pathology characteristics and survival was evaluated. Results The positive expression rate of HER2/c-erbB-2 in the cancer and paired normal gastric tissues were 32.8% (22/67) and 4.5% (3/67), respectively with statistical difference (p<0.05). And the positive expression rate of EGFR in cancer and paired normal gastric tissues were 41.8% (28/67) and 5.9 (4/67), respectively, with statistical difference (p<0.05). HER2/c-erbB-2 positive expression in cancer tissue was significant correlated with the pathology grading (p<0.05), tumor invasion depth (p<0.05) and local regional lymph node metastasis (p<0.05); EGFR positive expression in cancer tissue was significant correlated with the tumor invasion depth (p<0.05) and local regional lymph node metastasis (p<0.05). The median survival time was 13.14 and 23.6 months respectively for HER2/c-erbB-2 positive and negative expression groups respectively with statistical difference ( HR=2.26, 9%CI:1.06-4.80, p<0.05). However, the median survival time was 15.47 and 22.87 months for EGFR positive and negative expression groups respectively, without statistical difference (HR=1.78, 9%CI:0.96-3.29, p>0.05). Conclusion Positive expression of HER2/c-erbB-2 and EGFR proteins in cancer tissue was significant higher than normal gastric tissue and have significant correlation with prognosis.
Collapse
Affiliation(s)
- Guoxiong Cheng
- Department of Gastrointestinal surgery, Lishui Peoples’ Hospital of Zhejiang Province323000 PR, ZhejiangChina
| | - Yijun Mei
- Department of Gastrointestinal surgery, Lishui Peoples’ Hospital of Zhejiang Province323000 PR, ZhejiangChina
| | - Xiaoming Pan
- Department of Gastrointestinal surgery, Lishui Peoples’ Hospital of Zhejiang Province323000 PR, ZhejiangChina
| | - Ming Liu
- Department of Gastrointestinal surgery, Lishui Peoples’ Hospital of Zhejiang Province323000 PR, ZhejiangChina
| | - Suping Wu
- Department of Gastrointestinal surgery, Lishui Peoples’ Hospital of Zhejiang Province323000 PR, ZhejiangChina
- E-mail:
| |
Collapse
|
35
|
Alduino C, Alessandria F, Alfonso K, Andreotti E, Arnaboldi C, Avignone FT, Azzolini O, Balata M, Bandac I, Banks TI, Bari G, Barucci M, Beeman JW, Bellini F, Benato G, Bersani A, Biare D, Biassoni M, Bragazzi F, Branca A, Brofferio C, Bryant A, Buccheri A, Bucci C, Bulfon C, Camacho A, Caminata A, Canonica L, Cao XG, Capelli S, Capodiferro M, Cappelli L, Cardani L, Cariello M, Carniti P, Carrettoni M, Casali N, Cassina L, Cereseto R, Ceruti G, Chiarini A, Chiesa D, Chott N, Clemenza M, Conventi D, Copello S, Cosmelli C, Cremonesi O, Crescentini C, Creswick RJ, Cushman JS, D'Addabbo A, D'Aguanno D, Dafinei I, Datskov V, Davis CJ, Del Corso F, Dell'Oro S, Deninno MM, Di Domizio S, Di Vacri ML, Di Paolo L, Drobizhev A, Ejzak L, Faccini R, Fang DQ, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fujikawa BK, Gaigher R, Giachero A, Gironi L, Giuliani A, Gladstone L, Goett J, Gorla P, Gotti C, Guandalini C, Guerzoni M, Gutierrez TD, Haller EE, Han K, Hansen EV, Heeger KM, Hennings-Yeomans R, Hickerson KP, Huang HZ, Iannone M, Ioannucci L, Kadel R, Keppel G, Kogler L, Kolomensky YG, Leder A, Ligi C, Lim KE, Liu X, Ma YG, Maiano C, Maino M, Marini L, Martinez M, Martinez Amaya C, Maruyama RH, Mei Y, Moggi N, Morganti S, Mosteiro PJ, Nagorny SS, Napolitano T, Nastasi M, Nisi S, Nones C, Norman EB, Novati V, Nucciotti A, Nutini I, O'Donnell T, Olcese M, Olivieri E, Orio F, Orlandi D, Ouellet JL, Pagliarone CE, Pallavicini M, Palmieri V, Pattavina L, Pavan M, Pedretti M, Pedrotta R, Pelosi A, Pessina G, Pettinacci V, Piperno G, Pira C, Pirro S, Pozzi S, Previtali E, Reindl F, Rimondi F, Risegari L, Rosenfeld C, Rossi C, Rusconi C, Sakai M, Sala E, Salvioni C, Sangiorgio S, Santone D, Schaeffer D, Schmidt B, Schmidt J, Scielzo ND, Singh V, Sisti M, Smith AR, Stivanello F, Taffarello L, Tatananni L, Tenconi M, Terranova F, Tessaro M, Tomei C, Ventura G, Vignati M, Wagaarachchi SL, Wallig J, Wang BS, Wang HW, Welliver B, Wilson J, Wilson K, Winslow LA, Wise T, Zanotti L, Zarra C, Zhang GQ, Zhu BX, Zimmermann S, Zucchelli S. First Results from CUORE: A Search for Lepton Number Violation via 0νββ Decay of ^{130}Te. Phys Rev Lett 2018; 120:132501. [PMID: 29694201 DOI: 10.1103/physrevlett.120.132501] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/23/2017] [Indexed: 06/08/2023]
Abstract
The CUORE experiment, a ton-scale cryogenic bolometer array, recently began operation at the Laboratori Nazionali del Gran Sasso in Italy. The array represents a significant advancement in this technology, and in this work we apply it for the first time to a high-sensitivity search for a lepton-number-violating process: ^{130}Te neutrinoless double-beta decay. Examining a total TeO_{2} exposure of 86.3 kg yr, characterized by an effective energy resolution of (7.7±0.5) keV FWHM and a background in the region of interest of (0.014±0.002) counts/(keV kg yr), we find no evidence for neutrinoless double-beta decay. Including systematic uncertainties, we place a lower limit on the decay half-life of T_{1/2}^{0ν}(^{130}Te)>1.3×10^{25} yr (90% C.L.); the median statistical sensitivity of this search is 7.0×10^{24} yr. Combining this result with those of two earlier experiments, Cuoricino and CUORE-0, we find T_{1/2}^{0ν}(^{130}Te)>1.5×10^{25} yr (90% C.L.), which is the most stringent limit to date on this decay. Interpreting this result as a limit on the effective Majorana neutrino mass, we find m_{ββ}<(110-520) meV, where the range reflects the nuclear matrix element estimates employed.
Collapse
Affiliation(s)
- C Alduino
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | | | - K Alfonso
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - E Andreotti
- Dipartimento di Fisica e Matematica, Università dell'Insubria, Como I-22100, Italy
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - C Arnaboldi
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - O Azzolini
- INFN - Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - M Balata
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - I Bandac
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - T I Banks
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - G Bari
- INFN - Sezione di Bologna, Bologna I-40127, Italy
| | - M Barucci
- Dipartimento di Fisica, Università di Firenze, Firenze I-50125, Italy
- INFN - Sezione di Firenze, Firenze I-50125, Italy
| | - J W Beeman
- Materials Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - F Bellini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - G Benato
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - A Bersani
- INFN - Sezione di Genova, Genova I-16146, Italy
| | - D Biare
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Biassoni
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - F Bragazzi
- INFN - Sezione di Genova, Genova I-16146, Italy
| | - A Branca
- INFN - Sezione di Padova, Padova I-35131, Italy
| | - C Brofferio
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Bryant
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Buccheri
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - C Bucci
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - C Bulfon
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - A Camacho
- INFN - Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - A Caminata
- INFN - Sezione di Genova, Genova I-16146, Italy
| | - L Canonica
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - X G Cao
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - S Capelli
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | | | - L Cappelli
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Cardani
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - M Cariello
- INFN - Sezione di Genova, Genova I-16146, Italy
| | - P Carniti
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Carrettoni
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - N Casali
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - L Cassina
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - R Cereseto
- INFN - Sezione di Genova, Genova I-16146, Italy
| | - G Ceruti
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A Chiarini
- INFN - Sezione di Bologna, Bologna I-40127, Italy
| | - D Chiesa
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - N Chott
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Clemenza
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - D Conventi
- INFN - Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - S Copello
- INFN - Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - C Cosmelli
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - O Cremonesi
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | | | - R J Creswick
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - J S Cushman
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - A D'Addabbo
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - D D'Aguanno
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - I Dafinei
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - V Datskov
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - C J Davis
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - F Del Corso
- INFN - Sezione di Bologna, Bologna I-40127, Italy
| | - S Dell'Oro
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
- INFN - Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - M M Deninno
- INFN - Sezione di Bologna, Bologna I-40127, Italy
| | - S Di Domizio
- INFN - Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - M L Di Vacri
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila I-67100, Italy
| | - L Di Paolo
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Drobizhev
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Ejzak
- Department of Physics, University of Wisconsin, Madison, Wisconsin 53706, USA
| | - R Faccini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - D Q Fang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - M Faverzani
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Ferri
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - F Ferroni
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - E Fiorini
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M A Franceschi
- INFN - Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - S J Freedman
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B K Fujikawa
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Gaigher
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A Giachero
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Gironi
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A Giuliani
- CSNSM, Univ. Paris-Sud, CNRS/IN2P3, Universit Paris-Saclay, 91405 Orsay, France
| | - L Gladstone
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J Goett
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - P Gorla
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - C Gotti
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Guandalini
- INFN - Sezione di Bologna, Bologna I-40127, Italy
| | - M Guerzoni
- INFN - Sezione di Bologna, Bologna I-40127, Italy
| | - T D Gutierrez
- Physics Department, California Polytechnic State University, San Luis Obispo, California 93407, USA
| | - E E Haller
- Materials Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
- Department of Materials Science and Engineering, University of California, Berkeley, California 94720, USA
| | - K Han
- INPAC and School of Physics and Astronomy, Shanghai Jiao Tong University; Shanghai Laboratory for Particle Physics and Cosmology, Shanghai 200240, China
| | - E V Hansen
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - K M Heeger
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - R Hennings-Yeomans
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - K P Hickerson
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - H Z Huang
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - M Iannone
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - L Ioannucci
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - R Kadel
- Physics Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - G Keppel
- INFN - Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - L Kogler
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Yu G Kolomensky
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Leder
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - C Ligi
- INFN - Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - K E Lim
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - X Liu
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - Y G Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - C Maiano
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Maino
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - L Marini
- INFN - Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - M Martinez
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN - Sezione di Roma, Roma I-00185, Italy
- Laboratorio de Fisica Nuclear y Astroparticulas, Universidad de Zaragoza, Zaragoza 50009, Spain
| | - C Martinez Amaya
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - R H Maruyama
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - Y Mei
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N Moggi
- INFN - Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum - Università di Bologna, Bologna I-40127, Italy
| | - S Morganti
- INFN - Sezione di Roma, Roma I-00185, Italy
| | | | - S S Nagorny
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- INFN - Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - T Napolitano
- INFN - Laboratori Nazionali di Frascati, Frascati (Roma) I-00044, Italy
| | - M Nastasi
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - S Nisi
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - C Nones
- Service de Physique des Particules, CEA / Saclay, 91191 Gif-sur-Yvette, France
| | - E B Norman
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - V Novati
- CSNSM, Univ. Paris-Sud, CNRS/IN2P3, Universit Paris-Saclay, 91405 Orsay, France
| | - A Nucciotti
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - I Nutini
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- INFN - Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - T O'Donnell
- Center for Neutrino Physics, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - M Olcese
- INFN - Sezione di Genova, Genova I-16146, Italy
| | - E Olivieri
- Dipartimento di Fisica, Università di Firenze, Firenze I-50125, Italy
- INFN - Sezione di Firenze, Firenze I-50125, Italy
| | - F Orio
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - D Orlandi
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - J L Ouellet
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - C E Pagliarone
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - M Pallavicini
- INFN - Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - V Palmieri
- INFN - Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - L Pattavina
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Pavan
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Pedretti
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - R Pedrotta
- INFN - Sezione di Padova, Padova I-35131, Italy
| | - A Pelosi
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - G Pessina
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | | | - G Piperno
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - C Pira
- INFN - Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - S Pirro
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - S Pozzi
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - E Previtali
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - F Reindl
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - F Rimondi
- INFN - Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum - Università di Bologna, Bologna I-40127, Italy
| | - L Risegari
- Dipartimento di Fisica, Università di Firenze, Firenze I-50125, Italy
- INFN - Sezione di Firenze, Firenze I-50125, Italy
| | - C Rosenfeld
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Rossi
- INFN - Sezione di Genova, Genova I-16146, Italy
| | - C Rusconi
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Sakai
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - E Sala
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Salvioni
- Dipartimento di Fisica e Matematica, Università dell'Insubria, Como I-22100, Italy
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
| | - S Sangiorgio
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D Santone
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila I-67100, Italy
| | - D Schaeffer
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - B Schmidt
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Schmidt
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - N D Scielzo
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - V Singh
- Department of Physics, University of California, Berkeley, California 94720, USA
| | - M Sisti
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - A R Smith
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - F Stivanello
- INFN - Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | | | - L Tatananni
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - M Tenconi
- CSNSM, Univ. Paris-Sud, CNRS/IN2P3, Universit Paris-Saclay, 91405 Orsay, France
| | - F Terranova
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - M Tessaro
- INFN - Sezione di Padova, Padova I-35131, Italy
| | - C Tomei
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - G Ventura
- Dipartimento di Fisica, Università di Firenze, Firenze I-50125, Italy
- INFN - Sezione di Firenze, Firenze I-50125, Italy
| | - M Vignati
- INFN - Sezione di Roma, Roma I-00185, Italy
| | - S L Wagaarachchi
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Wallig
- Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B S Wang
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - H W Wang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - B Welliver
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - K Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - L A Winslow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - T Wise
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
- Department of Physics, University of Wisconsin, Madison, Wisconsin 53706, USA
| | - L Zanotti
- INFN - Sezione di Milano Bicocca, Milano I-20126, Italy
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
| | - C Zarra
- INFN - Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67100, Italy
| | - G Q Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - B X Zhu
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - S Zimmermann
- Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Zucchelli
- INFN - Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum - Università di Bologna, Bologna I-40127, Italy
| |
Collapse
|
36
|
Mei Y, Zhao B, Basiorka AA, Yang J, Cao L, Zhang J, List A, Ji P. Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS. Leukemia 2017; 32:1023-1033. [PMID: 29263441 PMCID: PMC5886057 DOI: 10.1038/leu.2017.326] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2017] [Revised: 10/22/2017] [Accepted: 10/26/2017] [Indexed: 12/04/2022]
Abstract
Anemia is characteristic of myelodysplastic syndromes (MDS). The mechanisms of anemia in MDS are unclear. Using a mouse genetic approach, here we show that dual deficiency of mDia1 and miR-146a, encoded on chromosome 5q and commonly deleted in MDS (del(5q) MDS), causes an age-related anemia and ineffective erythropoiesis mimicking human MDS. We demonstrate that the ageing bone marrow microenvironment is important for the development of ineffective erythropoiesis in these mice. Damage-associated molecular pattern molecules (DAMPs), whose levels increase in ageing bone marrow, induced TNFα and IL-6 upregulation in myeloid-derived suppressor cells (MDSCs) in mDia1/miR-146a double knockout mice. Mechanistically, we reveal that pathologic levels of TNFα and IL-6 inhibit erythroid colony formation and differentially affect terminal erythropoiesis through reactive oxygen species-induced caspase-3 activation and apoptosis. Treatment of the mDia1/miR-146a double knockout mice with all-trans retinoic acid, which promoted the differentiation of MDSCs and ameliorated the inflammatory bone marrow microenvironment, significantly rescued anemia and ineffective erythropoiesis. Our study underscores the dual roles of the ageing microenvironment and genetic abnormalities in the pathogenesis of ineffective erythropoiesis in del(5q) MDS.
Collapse
Affiliation(s)
- Y Mei
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - B Zhao
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - A A Basiorka
- Cancer Biology PhD Program, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida, Tampa, FL, USA
| | - J Yang
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - L Cao
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.,Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
| | - J Zhang
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - A List
- Cancer Biology PhD Program, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida, Tampa, FL, USA.,Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - P Ji
- Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| |
Collapse
|
37
|
Mei Y, Zhang Z. EFFECT OF COUPLE-BASED REMINISCENCE THERAPY ON ELDERLY STROKE SURVIVORS AND THEIR SPOUSE CAREGIVERS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.4237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Y. Mei
- School of Nursing, Zhengzhou, Henan Province, China,
- First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
| | - Z. Zhang
- School of Nursing, Zhengzhou, Henan Province, China,
| |
Collapse
|
38
|
Pyne M, Mallory M, Xie H, Mei Y, Schlaberg R, Hillyard D. Sequencing of the Hepatitis D Virus RNA WHO International Standard. J Clin Virol 2017; 90:52-56. [DOI: 10.1016/j.jcv.2017.03.009] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2017] [Revised: 03/10/2017] [Accepted: 03/15/2017] [Indexed: 01/16/2023]
|
39
|
D’Addabbo A, Alduino C, Alfonso K, Artusa DR, Avignone FT, Azzolini O, Banks TI, Bari G, Beeman J, Bellini F, Bersani A, Biassoni M, Branca A, Brofferio C, Bucci C, Camacho A, Caminata A, Canonica L, Cao XG, Capelli S, Cappelli L, Carbone L, Cardani L, Carniti P, Casali N, Cassina L, Chiesa D, Chott N, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick RJ, Cushman JS, Dafinei I, Davis CJ, Dell’Oro S, Deninno MM, Di Domizio S, Di Vacri ML, Drobizhev A, Fang DQ, Faverzani M, Fernandes G, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fujikawa BK, Giachero A, Gironi L, Giuliani A, Gladstone L, Gorla P, Gotti C, Gutierrez TD, Haller EE, Han K, Hansen E, Heeger KM, Hennings-Yeomans R, Hickerson KP, Huang HZ, Kadel R, Keppel G, Kolomensky YG, Leder A, Ligi C, Lim KE, Liu X, Ma YG, Maino M, Marini L, Martinez M, Maruyama RH, Mei Y, Moggi N, Morganti S, Mosteiro PJ, Napolitano T, Nones C, Norman EB, Nucciotti A, O’Donnell T, Orio F, Ouellet JL, Pagliarone CE, Pallavicini M, Palmieri V, Pattavina L, Pavan M, Pessina G, Pettinacci V, Piperno G, Pira C, Pirro S, Pozzi S, Previtali E, Rosenfeld C, Rusconi C, Sangiorgio S, Santone D, Scielzo N, Singh V, Sisti M, Smith AR, Taffarello L, Tenconi M, Terranova F, Tomei C, Trentalange S, Vignati M, Wagaarachchi SL, Wang BS, Wang HW, Wilson J, Winslow LA, Wise T, Woodcraft A, Zanotti L, Zhang GQ, Zhu BX, Zimmermann S, Zucchelli S. The CUORE and CUORE-0 experiments at LNGS. EPJ Web Conf 2017. [DOI: 10.1051/epjconf/201716407047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Cheng X, Mei Y, Ji X, Xue Q, Chen D. Molecular mechanism of the susceptibility difference between HLA-B*27:02/04/05 and HLA-B*27:06/09 to ankylosing spondylitis: substitution analysis, MD simulation, QSAR modelling, and in vitro assay. SAR QSAR Environ Res 2016; 27:409-425. [PMID: 27228481 DOI: 10.1080/1062936x.2016.1179672] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/14/2016] [Accepted: 04/13/2016] [Indexed: 06/05/2023]
Abstract
The human leukocyte antigen HLA-B27 is directly involved in the disease pathogenesis of ankylosing spondylitis (AS). HLA-B27 has a high degree of genetic polymorphism, with 105 currently known subtypes; the presence of aspartic acid at residue 116 (Asp116) has been found to play an essential role in AS susceptibility. Here, we systematically investigated the molecular mechanism of the susceptibility difference between the AS-associated subtypes HLA-B*27:02/04/05 and AS-unassociated subtypes HLA-B*27:06/09 to AS at sequence, structure, energetic and dynamic levels. In total seven variable residues were identified among the five studied HLA-B27 subtypes, in which Asp116 can be largely stabilized by a spatially vicinal, positively charged His114 through a salt bridge, while five other variable residues seem to have only a marginal effect on AS susceptibility. We also employed a quantitative structure-activity relationship approach to model the statistical correlation between peptide structure and affinity to HLA-B*27:05, a genetic ancestor of all other HLA-B27 subtypes and associated strongly with AS. The built regression predictor was verified rigorously through both internal cross-validation and external blind validation, and was then employed to identify potential HLA-B*27:05 binders from >20,000 cartilage-derived self-peptides. Subsequently, the binding potency of the top five antigenic peptides to HLA-B*27:05 was assayed in vitro using a FACS-based MHC stabilization experiment. Consequently, two (QRVGSDEFK and LRGAGTNEK) out of the five peptides were determined to have high affinity (BL50 = 5.5 and 15.8 nM, respectively) and, as expected, both of them possess positively charged Lys at the C-terminus.
Collapse
Affiliation(s)
- X Cheng
- a Department of Nephrology and Rheumatology, Affiliated Sixth People's Hospital , Shanghai Jiao Tong University , Shanghai , China
| | - Y Mei
- a Department of Nephrology and Rheumatology, Affiliated Sixth People's Hospital , Shanghai Jiao Tong University , Shanghai , China
| | - X Ji
- a Department of Nephrology and Rheumatology, Affiliated Sixth People's Hospital , Shanghai Jiao Tong University , Shanghai , China
| | - Q Xue
- a Department of Nephrology and Rheumatology, Affiliated Sixth People's Hospital , Shanghai Jiao Tong University , Shanghai , China
| | - D Chen
- b Department of Orthopaedics, Affiliated Sixth People's Hospital , Shanghai Jiao Tong University , Shanghai , China
| |
Collapse
|
41
|
Alfonso K, Artusa DR, Avignone FT, Azzolini O, Balata M, Banks TI, Bari G, Beeman JW, Bellini F, Bersani A, Biassoni M, Brofferio C, Bucci C, Caminata A, Canonica L, Cao XG, Capelli S, Cappelli L, Carbone L, Cardani L, Casali N, Cassina L, Chiesa D, Chott N, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick RJ, Cushman JS, Dafinei I, Dally A, Dell'Oro S, Deninno MM, Di Domizio S, Di Vacri ML, Drobizhev A, Ejzak L, Fang DQ, Faverzani M, Fernandes G, Ferri E, Ferroni F, Fiorini E, Freedman SJ, Fujikawa BK, Giachero A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Haller EE, Han K, Hansen E, Heeger KM, Hennings-Yeomans R, Hickerson KP, Huang HZ, Kadel R, Keppel G, Kolomensky YG, Lim KE, Liu X, Ma YG, Maino M, Martinez M, Maruyama RH, Mei Y, Moggi N, Morganti S, Nisi S, Nones C, Norman EB, Nucciotti A, O'Donnell T, Orio F, Orlandi D, Ouellet JL, Pagliarone CE, Pallavicini M, Palmieri V, Pattavina L, Pavan M, Pedretti M, Pessina G, Pettinacci V, Piperno G, Pirro S, Pozzi S, Previtali E, Rosenfeld C, Rusconi C, Sala E, Sangiorgio S, Santone D, Scielzo ND, Sisti M, Smith AR, Taffarello L, Tenconi M, Terranova F, Tomei C, Trentalange S, Ventura G, Vignati M, Wagaarachchi SL, Wang BS, Wang HW, Wielgus L, Wilson J, Winslow LA, Wise T, Zanotti L, Zarra C, Zhang GQ, Zhu BX, Zucchelli S. Search for Neutrinoless Double-Beta Decay of (130)Te with CUORE-0. Phys Rev Lett 2015; 115:102502. [PMID: 26382673 DOI: 10.1103/physrevlett.115.102502] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/09/2015] [Indexed: 06/05/2023]
Abstract
We report the results of a search for neutrinoless double-beta decay in a 9.8 kg yr exposure of (130)Te using a bolometric detector array, CUORE-0. The characteristic detector energy resolution and background level in the region of interest are 5.1±0.3 keV FWHM and 0.058±0.004(stat)±0.002(syst)counts/(keV kg yr), respectively. The median 90% C.L. lower-limit half-life sensitivity of the experiment is 2.9×10(24) yr and surpasses the sensitivity of previous searches. We find no evidence for neutrinoless double-beta decay of (130)Te and place a Bayesian lower bound on the decay half-life, T(1/2)(0ν)>2.7×10(24) yr at 90% C.L. Combining CUORE-0 data with the 19.75 kg yr exposure of (130)Te from the Cuoricino experiment we obtain T(1/2)(0ν)>4.0×10(24) yr at 90% C.L. (Bayesian), the most stringent limit to date on this half-life. Using a range of nuclear matrix element estimates we interpret this as a limit on the effective Majorana neutrino mass, m(ββ)<270-760 meV.
Collapse
Affiliation(s)
- K Alfonso
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - D R Artusa
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - F T Avignone
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - O Azzolini
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - M Balata
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - T I Banks
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - G Bari
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - J W Beeman
- Materials Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - F Bellini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - A Bersani
- INFN-Sezione di Genova, Genova I-16146, Italy
| | - M Biassoni
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - C Brofferio
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - C Bucci
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - A Caminata
- INFN-Sezione di Genova, Genova I-16146, Italy
| | - L Canonica
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - X G Cao
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - S Capelli
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - L Cappelli
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - L Carbone
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - L Cardani
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - N Casali
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - L Cassina
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - D Chiesa
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - N Chott
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - M Clemenza
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - S Copello
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - C Cosmelli
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - O Cremonesi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - R J Creswick
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - J S Cushman
- Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - I Dafinei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - A Dally
- Department of Physics, University of Wisconsin, Madison, Wisconsin 53706, USA
| | - S Dell'Oro
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
- INFN-Gran Sasso Science Institute, L'Aquila I-67100, Italy
| | - M M Deninno
- INFN-Sezione di Bologna, Bologna I-40127, Italy
| | - S Di Domizio
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - M L Di Vacri
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila I-67100, Italy
| | - A Drobizhev
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - L Ejzak
- Department of Physics, University of Wisconsin, Madison, Wisconsin 53706, USA
| | - D Q Fang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - M Faverzani
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - G Fernandes
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - E Ferri
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - F Ferroni
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - E Fiorini
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - S J Freedman
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B K Fujikawa
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Giachero
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - L Gironi
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A Giuliani
- Centre de Sciences Nucléaires et de Sciences de la Matière (CSNSM), 91405 Orsay Campus, Orsay, France
| | - P Gorla
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - C Gotti
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - T D Gutierrez
- Physics Department, California Polytechnic State University, San Luis Obispo, California 93407, USA
| | - E E Haller
- Materials Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
- Department of Materials Science and Engineering, University of California, Berkeley, California 94720, USA
| | - K Han
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
- Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - E Hansen
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - K M Heeger
- Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - R Hennings-Yeomans
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - K P Hickerson
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - H Z Huang
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - R Kadel
- Physics Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - G Keppel
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - Yu G Kolomensky
- Department of Physics, University of California, Berkeley, California 94720, USA
- Physics Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - K E Lim
- Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - X Liu
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - Y G Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - M Maino
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - M Martinez
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- Laboratorio de Fisica Nuclear y Astroparticulas, Universidad de Zaragoza, Zaragoza 50009, Spain
| | - R H Maruyama
- Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - Y Mei
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - N Moggi
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Scienze per la Qualità della Vita, Alma Mater Studiorum-Università di Bologna, Bologna I-47921, Italy
| | - S Morganti
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S Nisi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - C Nones
- CEA, Centre de Saclay, Irfu/SPP, F-91191 Gif-sur-Yvette, France
| | - E B Norman
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - A Nucciotti
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - T O'Donnell
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - F Orio
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - D Orlandi
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - J L Ouellet
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - C E Pagliarone
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
- Dipartimento di Ingegneria Civile e Meccanica, Università degli Studi di Cassino e del Lazio Meridionale, Cassino I-03043, Italy
| | - M Pallavicini
- INFN-Sezione di Genova, Genova I-16146, Italy
- Dipartimento di Fisica, Università di Genova, Genova I-16146, Italy
| | - V Palmieri
- INFN-Laboratori Nazionali di Legnaro, Legnaro (Padova) I-35020, Italy
| | - L Pattavina
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - M Pavan
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - M Pedretti
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - G Pessina
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | | | - G Piperno
- Dipartimento di Fisica, Sapienza Università di Roma, Roma I-00185, Italy
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S Pirro
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - S Pozzi
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - E Previtali
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - C Rosenfeld
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - C Rusconi
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - E Sala
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - S Sangiorgio
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - D Santone
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, L'Aquila I-67100, Italy
| | - N D Scielzo
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - M Sisti
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - A R Smith
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - M Tenconi
- Centre de Sciences Nucléaires et de Sciences de la Matière (CSNSM), 91405 Orsay Campus, Orsay, France
| | - F Terranova
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - C Tomei
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S Trentalange
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - G Ventura
- Dipartimento di Fisica, Università di Firenze, Firenze I-50125, Italy
- INFN-Sezione di Firenze, Firenze I-50125, Italy
| | - M Vignati
- INFN-Sezione di Roma, Roma I-00185, Italy
| | - S L Wagaarachchi
- Department of Physics, University of California, Berkeley, California 94720, USA
- Nuclear Science Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - B S Wang
- Lawrence Livermore National Laboratory, Livermore, California 94550, USA
- Department of Nuclear Engineering, University of California, Berkeley, California 94720, USA
| | - H W Wang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - L Wielgus
- Department of Physics, University of Wisconsin, Madison, Wisconsin 53706, USA
| | - J Wilson
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - L A Winslow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - T Wise
- Department of Physics, Yale University, New Haven, Connecticut 06520, USA
- Department of Physics, University of Wisconsin, Madison, Wisconsin 53706, USA
| | - L Zanotti
- Dipartimento di Fisica, Università di Milano-Bicocca, Milano I-20126, Italy
- INFN-Sezione di Milano Bicocca, Milano I-20126, Italy
| | - C Zarra
- INFN-Laboratori Nazionali del Gran Sasso, Assergi (L'Aquila) I-67010, Italy
| | - G Q Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - B X Zhu
- Department of Physics and Astronomy, University of California, Los Angeles, California 90095, USA
| | - S Zucchelli
- INFN-Sezione di Bologna, Bologna I-40127, Italy
- Dipartimento di Fisica e Astronomia, Alma Mater Studiorum-Università di Bologna, Bologna I-40127, Italy
| |
Collapse
|
42
|
Li L, Li T, Zhang Y, Pan Z, Wu B, Huang X, Zhang Y, Mei Y, Ge L, Shen G, Ge RS, Zhu D, Lou Y. Peroxisome proliferator-activated receptorβ/δ activation is essential for modulating p-Foxo1/Foxo1 status in functional insulin-positive cell differentiation. Cell Death Dis 2015; 6:e1715. [PMID: 25855963 PMCID: PMC4650555 DOI: 10.1038/cddis.2015.88] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2014] [Revised: 02/26/2015] [Accepted: 03/02/2015] [Indexed: 11/25/2022]
Abstract
Peroxisome proliferator-activated receptors (PPARs) participate in energy homeostasis and play essential roles in diabetes therapy through their effects on non-pancreas tissues. Pathological microenvironment may influence the metabolic requirements for the maintenance of stem cell differentiation. Accordingly, understanding the mechanisms of PPARs on pancreatic β-cell differentiation may be helpful to find the underlying targets of disrupted energy homeostasis under the pancreatic disease condition. PPARs are involved in stem cell differentiation via mitochondrial oxidative phosphorylation, but the subtype member activation and the downstream regulation in functional insulin-positive (INS+) cell differentiation remain unclear. Here, we show a novel role of PPARβ/δ activation in determining INS+ cell differentiation and functional maturation. We found PPARβ/δ expression selectively upregulated in mouse embryonic pancreases or stem cells-derived INS+ cells at the pancreatic mature stage in vivo and in vitro. Strikingly, given the inefficiency of generating INS+ cells in vitro, PPARβ/δ activation displayed increasing mouse and human ES cell-derived INS+ cell numbers and insulin secretion. This phenomenon was closely associated with the forkhead box protein O1 (Foxo1) nuclear shuttling, which was dependent on PPARβ/δ downstream PI3K/Akt signaling transduction. The present study reveals the essential role of PPARβ/δ activation on p-Foxo1/Foxo1 status, and in turn, determining INS+ cell generation and insulin secretion via affecting pancreatic and duodenal homeobox-1 expression. The results demonstrate the underlying mechanism by which PPARβ/δ activation promotes functional INS+ cell differentiation. It also provides potential targets for anti-diabetes drug discovery and hopeful clinical applications in human cell therapy.
Collapse
Affiliation(s)
- L Li
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - T Li
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Y Zhang
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Z Pan
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - B Wu
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - X Huang
- Cardiovascular Key Laboratory of Zhejiang Province, The 2nd Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
| | - Y Zhang
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Y Mei
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - L Ge
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - G Shen
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - R-s Ge
- 1] The Population Council at the Rockefeller University, New York, NY 10021, USA [2] Institute of Reproductive Biomedicine, the 2nd Affiliated Hospital, Wenzhou Medical University, Wenzhou, China
| | - D Zhu
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| | - Y Lou
- Institute of Pharmacology, Toxicology and Biochemical Pharmaceutics, Key Innovation Team for Stem Cell Translational Medicine of Cardiovascular Disease of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
| |
Collapse
|
43
|
Ji P, Zhao B, Mei Y. 281 LOSS OF MDIA1 MEDIATES THE DEVELOPMENT OF DEL(5Q) MDS THROUGH UPREGULATION OF THE INNATE IMMUNE RESPONSE AND INDUCTION OF NEUTROPENIA. Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30282-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Moggi N, Artusa DR, Avignone FT, Azzolini O, Balata M, Banks TI, Bari G, Beeman J, Bellini F, Bersani A, Biassoni M, Brofferio C, Bucci C, Cai XZ, Camacho A, Caminata A, Canonica L, Cao XG, Capelli S, Cappelli L, Carbone L, Cardani L, Casali N, Cassina L, Chiesa D, Chott N, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick RJ, Cushman JS, Dafinei I, Dally A, Datskov V, Dell’oro S, Deninno MM, Di Domizio S, Di Vacri ML, Drobizhev A, Ejzak L, Fang DQ, Farach HA, Faverzani M, Fernandes G, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fujikawa BK, Giachero A, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Haller EE, Han K, Heeger KM, Hennings-Yeomans R, Hickerson KP, Huang HZ, Kadel R, Keppel G, Kolomensky YG, Li YL, Ligi C, Lim KE, Liu X, Ma YG, Maiano C, Maino M, Martinez M, Maruyama RH, Mei Y, Morganti S, Napolitano T, Nisi S, Nones C, Norman EB, Nucciotti A, O’Donnell T, Orio F, Orlandi D, Ouellet JL, Pagliarone CE, Pallavicini M, Palmieri V, Pattavina L, Pavan M, Pessina G, Pettinacci V, Piperno G, Pira C, Pirro S, Pozzi S, Previtali E, Rosenfeld C, Rusconi C, Sala E, Sangiorgio S, Santone D, Scielzo ND, Sisti M, Smith AR, Taffarello L, Tenconi M, Terranova F, Tian WD, Tomei C, Trentalange S, Ventura G, Vignati M, Wang BS, Wang HW, Wielgus L, Wilson J, Winslow LA, Wise T, Woodcraft A, Zanotti L, Zarra C, Zhang GQ, Zhu BX, Zucchelli S. Neutrinoless double-beta decay search with CUORE and CUORE-0 experiments. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20159003004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
45
|
Liang H, Guan W, Yang Y, Mao Z, Mei Y, Liu H, Miao Y. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional study. J Biomed Res 2015; 29:112-7. [PMID: 25859265 PMCID: PMC4389110 DOI: 10.7555/jbr.29.20140109] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2014] [Revised: 09/26/2014] [Accepted: 12/29/2014] [Indexed: 01/14/2023] Open
Abstract
Roux-en-Y gastric bypass surgery (RYGB) has been demonstrated to be successful for treating type-II diabetes mellitus (T2DM) patients with a body mass index (BMI) <30 kg/m(2), but reports of RYGB for T2DM patients with a BMI <28 kg/m(2) are lacking. T2DM patients with a BMI <28 kg/m(2) were prospectively recruited to participate in this study in four hospitals. The endpoint was T2DM remission (defined by fasting blood glucose (FBG) level <110 mg/dL and hemoglobin (Hb)A1c level <6.0% at 12 months postoperatively). Predictors of remission were investigated by univariate and multivariate analyses. Eighty-six patients were assessed. Eighty-five patients underwent RYGB, with one conversion to open surgery. We compared the values of various variables before and after surgery. The mean BMI decreased from 24.68±2.12 to 21.72±2.43 kg/m(2) (P<0.001). Fifty-eight (67.4%) patients were not treated by drugs or insulin after surgery, and 20 patients (23.3%) had complete remission of T2DM at 12 months after surgery with an acceptable number of complications. The mean HbA1c level in the remission group was significantly lower than that in the non-remission group. Patients with a higher weight, lower HbA1c level, higher C-peptide level, and higher FBG level were more likely to have T2DM remission in multivariate analyses. In conclusion, RYGB was effective and safe for treating T2DM patients with a BMI <28 kg/m(2). Complete remission can be predicted by cases having a higher weight, lower HbA1c level, higher C-peptide level, and higher FBG level.
Collapse
Affiliation(s)
- Hui Liang
- Department of General Surgery, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China
| | - Wei Guan
- Department of General Surgery, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China
| | - Yanling Yang
- Department of General Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710032, China
| | - Zhongqi Mao
- Department of General Surgery, The First Affiliated Hospital, Suzhou University, Suzhou, Jiangsu 215006, China
| | - Yijun Mei
- Department of General Surgery, The Sixth Affiliated Hospital, Wenzhou Medical University, Lishui, Jiangsu 323000, China
| | - Huan Liu
- Department of General Surgery, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China
| | - Yi Miao
- Department of General Surgery, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, China
| |
Collapse
|
46
|
Giachero A, Artusa DR, Avignone FT, Azzolini O, Balata M, Banks TI, Bari G, Beeman J, Bellini F, Bersani A, Biassoni M, Brofferio C, Bucci C, Cai XZ, Camacho A, Caminata A, Canonica L, Cao XG, Capelli S, Cappelli L, Carbone L, Cardani L, Casali N, Cassina L, Chiesa D, Chott N, Clemenza M, Copello S, Cosmelli C, Cremonesi O, Creswick R, Cushman J, Dafinei I, Dally A, Datskov V, Dell’Oro S, Deninno MM, Di Domizio S, di Vacri ML, Drobizhev A, Ejzak L, Fang DQ, Farach HA, Faverzani M, Fernandes G, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fujikawa BK, Gironi L, Giuliani A, Gorla P, Gotti C, Gutierrez TD, Haller EE, Han K, Heeger KM, Hennings-Yeomans R, Hickerson KP, Huang HZ, Kadel R, Kazkaz K, Keppel G, Kolomensky Y, Li Y, Ligi C, Lim KE, Liu X, Ma YG, Maiano C, Maino M, Martinez M, Maruyama RH, Mei Y, Moggi N, Morganti S, Napolitano T, Nastasi M, Nisi S, Nones C, Norman EB, Nucciotti A, O’Donnell T, Orio F, Orlandi D, Ouellet JL, Pagliarone CE, Pallavicini M, Pattavina L, Pavan M, Pedretti M, Pessina G, Pettinacci V, Piperno G, Pira C, Pirro S, Pozzi S, Previtali E, Rampazzo V, Rosenfeld C, Rusconi C, Sala E, Sangiorgio S, Scielzo ND, Sisti M, Smith AR, Taffarello L, Tenconi M, Terranova F, Tian WD, Tomei C, Trentalange S, Ventura G, Vignati M, Wang BS, Wang HW, Wielgus L, Wilson J, Winslow LA, Wise T, Woodcraft A, Zanotti L, Zarra C, Zhang GQ, Zhu BX, Zucchelli S. The CUORE and CUORE-0 experiments at Gran Sasso. EPJ Web of Conferences 2015. [DOI: 10.1051/epjconf/20159504024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Demirel S, Chen D, Mei Y, Partovi S, von Tengg-Kobligk H, Dadrich M, Böckler D, Kauczor HU, Müller-Eschner M. Comparison of morphological and rheological conditions between conventional and eversion carotid endarterectomy using computational fluid dynamics – a pilot study. Vascular 2014; 23:474-82. [DOI: 10.1177/1708538114552836] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Purpose: To compare postoperative morphological and rheological conditions after eversion carotid endarterectomy versus conventional carotid endarterectomy using computational fluid dynamics. Basic methods: Hemodynamic metrics (velocity, wall shear stress, time-averaged wall shear stress and temporal gradient wall shear stress) in the carotid arteries were simulated in one patient after conventional carotid endarterectomy and one patient after eversion carotid endarterectomy by computational fluid dynamics analysis based on patient specific data. Principal findings: Systolic peak of the eversion carotid endarterectomy model showed a gradually decreased pressure along the stream path, the conventional carotid endarterectomy model revealed high pressure (about 180 Pa) at the carotid bulb. Regions of low wall shear stress in the conventional carotid endarterectomy model were much larger than that in the eversion carotid endarterectomy model and with lower time-averaged wall shear stress values (conventional carotid endarterectomy: 0.03–5.46 Pa vs. eversion carotid endarterectomy: 0.12–5.22 Pa). Conclusions: Computational fluid dynamics after conventional carotid endarterectomy and eversion carotid endarterectomy disclosed differences in hemodynamic patterns. Larger studies are necessary to assess whether these differences are consistent and might explain different rates of restenosis in both techniques.
Collapse
Affiliation(s)
- S Demirel
- Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany
| | - D Chen
- Department of Biomedical Engineering, School of Life Science, Beijing Institute of Technology, Beijing, China
| | - Y Mei
- Department of Biomedical Engineering, School of Life Science, Beijing Institute of Technology, Beijing, China
| | - S Partovi
- Department of Radiology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, USA
| | - H von Tengg-Kobligk
- Institute of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern, Inselspital, Bern, Switzerland
- Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
| | - M Dadrich
- Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
- Department of Radiology, German Cancer Research Center (dkfz), Heidelberg, Germany
| | - D Böckler
- Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany
| | - HU Kauczor
- Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
| | - M Müller-Eschner
- Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
- Department of Radiology, German Cancer Research Center (dkfz), Heidelberg, Germany
| |
Collapse
|
48
|
Hu W, Jin L, Jiang CC, Long GV, Scolyer RA, Wu Q, Zhang XD, Mei Y, Wu M. AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma. Cell Death Dis 2013; 4:e914. [PMID: 24201813 PMCID: PMC3847319 DOI: 10.1038/cddis.2013.441] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2013] [Revised: 09/30/2013] [Accepted: 10/04/2013] [Indexed: 01/06/2023]
Abstract
An activating BRAF (V600E) kinase mutation occurs in approximately half of melanomas. Recent clinical studies have demonstrated that vemurafenib (PLX4032) and dabrafenib, potent and selective inhibitors of mutant v-raf murine sarcoma viral oncogene homolog B1 (BRAF), exhibit remarkable activities in patients with V600 BRAF mutant melanomas. However, acquired drug resistance invariably develops after the initial treatment. Identification of acquired resistance mechanisms may inform the development of new therapies that elicit long-term responses of melanomas to BRAF inhibitors. Here we report that increased expression of AEBP1 (adipocyte enhancer-binding protein 1) confers acquired resistance to BRAF inhibition in melanoma. AEBP1 is shown to be highly upregulated in PLX4032-resistant melanoma cells because of the hyperactivation of the PI3K/Akt-cAMP response element-binding protein (CREB) signaling pathway. This upregulates AEBP1 expression and thus leads to the activation of NF-κB via accelerating IκBa degradation. In addition, inhibition of the PI3K/Akt-CREB-AEBP1-NF-κB pathway greatly reverses the PLX4032-resistant phenotype of melanoma cells. Furthermore, increased expression of AEBP1 is validated in post-treatment tumors in patients with acquired resistance to BRAF inhibitor. Therefore, these results reveal a novel PI3K/Akt-CREB-AEBP1-NF-κB pathway whose activation contributes to acquired resistance to BRAF inhibition, and suggest that this pathway, particularly AEBP1, may represent a novel therapeutic target for treating BRAF inhibitor-resistant melanoma.
Collapse
Affiliation(s)
- W Hu
- 1] Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China, Anhui, China [2] Department of Immunology, Anhui Medical University, Anhui, China
| | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Xie W, Xie H, Liu F, Li W, Dan J, Mei Y, Dan L, Xiao X, Li J, Chen X. Propranolol induces apoptosis of human umbilical vein endothelial cells through downregulation of CD147. Br J Dermatol 2013; 168:739-48. [PMID: 23528058 DOI: 10.1111/bjd.12193] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND Infantile haemangiomas (IHs) are benign tumours in infancy. Most patients suffering from IHs do not require treatment. However, if there is a dramatic aesthetic or functional impairment, treatment is needed. Currently the most promising therapy for complicated IHs is the oral administration of propranolol, but its mechanism is unclear. OBJECTIVES To investigate the role of CD147 in propranolol-induced apoptosis in human umbilical vein endothelial cells (HUVECs). METHODS Human umbilical vein endothelial cells were treated with propranolol, and the treatment effects were investigated through the following methodology. (i) Cell proliferation and apoptosis were detected using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometric analysis. (ii) The expression level of CD147 was measured by reverse-transcription polymerase chain reaction and Western blotting. (iii) HUVECs were transfected with lentivirus encoding CD147 short hairpin (sh)RNA or CD147 cDNA. Ensuing changes in cell proliferation and apoptosis after transfection were measured using the MTT assay and flow cytometry. (iv) The level of phosphorylation of Bcl-2-associated death promoter (BAD) at Ser112 in HUVECs after propranolol treatment and/or CD147 shRNA transfection was detected by Western blotting. RESULTS Propranolol inhibited cell proliferation and induced apoptosis in HUVECs. It decreased CD147 protein expression in a concentration-dependent manner. Knocking down CD147 not only induced apoptosis but also exacerbated the apoptosis triggered by propranolol in HUVECs. Overexpression of CD147 can protect HUVECs from apoptosis and propranolol-induced apoptosis. Furthermore, knockdown of both propranolol and CD147 can downregulate Ser112 phosphorylation of BAD, indicating that propranolol and CD147 induce apoptosis in HUVECs through the same signalling transduction pathway. CONCLUSIONS Our studies demonstrate that propranolol-induced apoptosis may be mediated through the downregulation of CD147 in HUVECs. This study highlights a novel step in propranolol action and suggests a potential new target for the treatment of IHs.
Collapse
Affiliation(s)
- W Xie
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Wang SY, Duan KM, Li Y, Mei Y, Sheng H, Liu H, Mei X, Ouyang W, Zhou HH, Liu ZQ. Effect of quercetin on P-glycoprotein transport ability in Chinese healthy subjects. Eur J Clin Nutr 2013; 67:390-4. [DOI: 10.1038/ejcn.2013.5] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|